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Following myocardial infarction, elevated sympathetic neuronal 
sprouting at the infarct border region leads to hyperexcitability which 
increases the risk of arrhythmias and sudden cardiac death. Surviving 
individuals with impaired cardiac functions are prone to develop congestive 
heart failure, which is also associated with sympathetic hyperexcitability. As a 
result, β-adrenergic receptor blockers are commonly administered to reduce 
adverse symptoms. Therefore our first goal was to attenuate inflammation in 
order to reduce sympathetic hyperinnervation in the infarct border region. Our 
second goal was to study the effect of β-blockers on cardiac sympathetic 
innervation. 
Inflammatory cells in the infarct release nerve growth factor (NGF) 
contributing to sympathetic neuronal sprouting. To reduce inflammation, we 
administered dexamethasone post-infarction. Although the treatment reduced 
body weight, it failed to reduce infarct sympathetic hyperinnervation. 
However, dexamethasone is not a selective treatment and may have side 
effects that promote neuronal sprouting. Because our lab had previously 
shown that macrophages within the infarct express NGF, we depleted 
macrophages by clodronate liposome administration. In association with 
macrophage reduction, the number of myofibroblasts was slightly decreased 
but T-cell numbers were unchanged. Immunoblots showed that mature NGF 
was decreased by clodronate liposome treatment, and this change resulted 
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mainly from the decrease of NGF-immunoreactivity (-ir) in macrophages and 
to a lesser extent NGF-ir in myofibroblast, but NGF-ir in T-cells was not 
altered. In concert with the reduction of NGF, sympathetic hyperinnervation 
was suppressed. These findings suggest that macrophage NGF expression is 
central to the development of sympathetic hyperinnervation and may be a 
valuable therapeutic target.   
Secondly, α or β-blockers were administered post-infarction. While 
border region sympathetic hyperinnervation was unchanged, β-blockers 
substantially increased sympathetic innervation in non-ischemic regions of the 
heart. Control hearts displayed similar hyperinnervation and administration of 
metoprolol showed that this response was selective for β1-blockade. While 
two days after β-blocker treatment withdrawal, adrenergic receptors were not 
supersensitized, ventricular functions were enhanced by neuronal 
norepinephrine store release with tyramine, consistent with increased 
sympathetic neuroeffector functions. To determine if β-adrenoceptor 
activation modulates sympathetic innervation density via cardiac NGF 
synthesis, norepinephrine release was suppressed by chemical 
sympathectomy. Sympathetic depletion upregulated the translation of some 
proNGF isoforms but total NGF was unchanged. Consistently, adrenergic 
receptor activation did not modulate cardiomyocyte NGF synthesis in vitro. To 
examine potential direct effects of β-blockers on sympathetic neurons, 
cultures were incubated with propranolol or metoprolol, and these treatments 
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resulted in elevated outgrowth. Similarly, the inhibition of norepinephrine 
synthesis by α-methyl-p-tyrosine enhanced sprouting. Simultaneous 
incubation in dobutamine reversed outgrowth confirming that sympathetic 
plasticity is regulated by β1 adrenergic auto-receptors.  
In conclusion, targeting macrophage NGF synthesis may provide a 
valuable strategy to reduce border region sympathetic hyperinnervation. In 
addition, despite the wide clinical use of β-blockers, cardiac sympathetic 
hyperinnervation resulting from the treatment can alter ventricular functions 




























Cardiovascular disease (CVD) is the leading cause of death in the 
United States, accounting for approximately 35% of all deaths. Currently, 
~80,000,000 Americans have one or more types of CVD and the cost 
associated with the disease is estimated at $475.3 billion for 2009 (Lloyd-
Jones, et al., 2009). The prevalence of CVD increases with age and with a 
lower education level, however a healthy life style including no smoking, 
maintaining a healthy weight, consuming 5 fruits and vegetables per day as 
well as performing regular physical activities can reduce chances of 
developing CVD (Lloyd-Jones, et al., 2009). Coronary heart disease alone 
accounts for ~ 21% of all CVD (Lloyd-Jones, et al., 2009) and can lead to 
myocardial infarction (MI) which is caused by thrombosis in a coronary artery. 
In 2009, it is estimated that ~785 000 Americans will have a new MI and 
~470,000 will have a recurrent MI, including ~21% silent MIs. On average, 
MIs reduce life span by approximately 15 years (Lloyd-Jones, et al., 2009).   
The main cause of CVD is atherosclerosis, a syndrome characterized 
by accumulation of fatty deposits and inflammatory cells within the wall of the 
arteries. These plaques can cause hardening of the arteries leading to their 
enlargement in order to compensate for the reduced blood flow. The stress on 
the artery wall eventually results in either plaque rupture which can lead to the 
formation of a thrombus that obstructs the artery, or to aneurysm (Fuster, et 
al., 2007).   
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The inflammatory cascade post-MI 
Complete closure of a coronary artery by a thrombus leads to ischemia 
and necrosis of the ventricle. Ventricular functions are impaired and can result 
in immediate organ failure. When the damage is less extensive, a complex 
inflammatory cascade is triggered in order to repair the necrosed area. Infarct 
healing is divided into three overlapping phases: the inflammatory phase, the 
proliferative phase, and the maturation phase (Frangogiannis, 2006).  
During the inflammatory phase, secreted chemokines and cytokines 
attract neutrophils into the infarcted area. This is followed by the recruitment 
and the proliferation of other inflammatory cells including macrophages which 
phagocytose matrix debris and dead cells. During this process, macrophage 
become activated leading to the upregulation of many secreted factors 
(Adams, et al., 1984, Caroleo, et al., 2001). The next phase is characterized 
by the development of a microvascular network and of sympathetic axonal 
sprouting. Proliferation of fibroblasts and endothelial cells is suppressed. 
Myofibroblasts which are thought to transdifferentiate from different cell types 
(Schmitt-Graff, et al., 1994, Hasan, et al., 2000) secrete extracellular matrix 
proteins (DiPietro LA., 2003). During the maturation phase, inflammatory cells 






Remodeling of sympathetic innervations post-MI  
Post-infarction ventricular remodeling induces extensive modifications 
of the sympathetic nervous system. This system plays a critical role in the 
heart by enhancing conduction through the heart which increases 
chronotropy, inotropy and electrical conduction velocity. Normal conduction 
through the heart starts at the pacemaker cells in the sino-atrial (SA) node on 
the right atrium. The impulse is passed along cardiomyocytes through gap 
junctions inducing their contraction. The internodal pathway rapidly conducts 
the impulse to the atrio-ventricular (AV) node located at the junction between 
the atria and the ventricle. The impulse is then conducted from the bundle of 
His to the Purkinje fibers down the septal wall to the apex of the heart. It is 
subsequently dispersed through the ventricle wall back to the base of the 
heart. Cardiomyocyte contraction induces blood to be pumped out of the 
ventricles and of the atria (Fuster, et al., 2007).  
 Myocardial infarction is believed to interfere with the electrical 
conduction through the heart two fold, first by causing a necrosed area 
disrupting cardiomyocyte impulses and by promoting the degeneration of the 
axons traveling through that lesion, second, by causing sympathetic 
hyperinnervation and hyperexcitability in the border region of the infarct 
(Martins, et al., 1980, Zipes, 1990).  
These finding have been demonstrated by performing chemical or 
electrical stimulations of the ventricle and measuring responses. Contraction 
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of the ischemic region was improved by exogenous norepinephrine 
administration while sympathetic nerve stimulation had no effect (Martins, et 
al., 1980). Further, to determine the viability of the fibers above and below the 
infarct, electrodes were positioned and the effective refractory period (ERP) 
was measured during left and right sympathetic nerve stimulation of the 
stellate ganglion. The results demonstrated that ERP was shortened in sites 
above the infarct 1 to 3 weeks after infarction, unlike in regions below the 
infarct, which presented shortened ERP prior to infarction (Zipes, 1990). 
Moreover, norepinephrine  from tissue biopsies of sites with shortened ERP 
were elevated (Zipes, 1990). Because non-uniform excitations of the ventricle 
can provoke arrhythmias (Han, et al., 1964, Kralios, et al., 1975), post-
infarction modifications of the sympathetic innervations could cause 
arrhythmias. 
 Additionally, changes in the pattern of sympathetic nerves were 
observed in concert with post-infarction adverse symptoms. Regenerating 
nerve fibers stained with S-100 were observed besides spindle-shaped cells 
oriented along the axis of the myocytes. Both populations were found to move 
sequentially toward the center of each lesion following infarction in rats 
(Vracko, et al., 1990). Neuronal proliferation was also observed at the 
periphery of the infarct in human hearts (Vracko, et al., 1991) and this 
sympathetic sprouting was correlated with previous arrhythmogenesis (Cao, 
et al., 2000b). Together, these studies demonstrated that post-infarction 
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cardiac nerve sprouting is associated with serious adverse effects. To 
understand the mechanisms causing neuronal sprouting, we and others 
studied its relationship with nerve growth factor (NGF) (Hiltunen, et al., 2001, 
Zhou, et al., 2004, Hasan, et al., 2006). 
 
The role of NGF post-MI 
NGF is a potent sympathetic neurotrophin and is critical for proper 
target innervation (Levi-Montalcini, 1987). Neurotrophins bind to members of 
the Trk family receptor with a high affinity, and p75 receptor can strengthen 
this interaction. Activation of the Trk receptors induces neuronal differentiation 
and survival (Levi-Montalcini, 1987). In the absence of Trk receptors, 
neurotrophins bind to p75 which can lead to apoptosis (Lee, et al., 2001, 
Fahnestock, et al., 2004). NGF has a number of different molecular weight 
isoforms. RNA splice variants are translated into proteins that can be 
glycosylated and sulfonated. Those can then be cleaved intracellularly and 
extracellularly by furin (Boutilier, et al., 2008) or extracellular matrix 
metalloproteinases (MMPs) and by serine protease plasmin (Lee, et al., 
2001). The higher molecular weight proNGFs have a higher affinity for p75 
receptor while the mature ~14 kD isoform preferentially binds to TrkA receptor 
(Lee, et al., 2001). The various NGF isoforms have been implicated in a 
variety of developmental and physiological processes (Shelton, et al., 1984, 
Levi-Montalcini, 1987, Young, et al., 2004), which are mediated by 
7 
 
intracellular NGF taken up at the periphery and retrogradely transported to 
the cell body (Stoeckel, et al., 1975).  
Enhanced cardiac sympathetic innervation by infusion of NGF to the 
left stellate ganglion increased ventricular tachycardia, ventricular fibrillation 
and sudden cardiac death (Chen, et al., 2001) implying that NGF may lead to 
those adverse effect following myocardial infarction. Macrophages and 
myofibroblasts were found to express high levels of NGF (Hasan, et al., 
2006), which peaked 7 days after myocardial infarction causing sympathetic 
innervation to peak at the same time (Zhou, et al., 2004, Hasan, et al., 2006). 
In explant co-cultures, infarcted tissue was most neuritogenic 7 days post- 
infarction, inducing enhanced sympathetic neuronal sprouting from the 
ganglion (Hasan, et al., 2006). Moreover, neutralizing NGF with anti-NGF 
antibody in those cultures suppressed hyperinnervation confirming the direct 
relationship between NGF and hyperinnervation (Hasan, et al., 2006). Thus, 
NGF appears central to the development of sympathetic hyperinnervation in 
the infarct border region.  
 
Reducing border region hyperinnervation by decreasing inflammation 
The inflammatory environment is known to promote sympathetic 
neuronal sprouting by releasing NGF, thus we administered the anti-
inflammatory glucocorticoid dexamethasone to reduce inflammation and we 
studied sympathetic hyperinnervation. As a more selective approach, we 
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identified the role of macrophage depletion on sympathetic hyperinnervation 
by injecting clodronate liposomes (Van Rooijen, et al., 1994). Macrophages 
were previously found to synthesize NGF in the border region and their 
proliferation coincides with cardiac nerves sprouting (Hasan, et al., 2006) . 
The activation of macrophages promotes NGF overexpression in vitro 
(Caroleo, et al., 2001) suggesting that the inflammatory environment of the 
infarct may be prone to releasing high NGF levels as a result of macrophage 
recruitment and activation. Therefore, reducing macrophage NGF may 
provide a selective therapeutic target to reduce hyperinnervation.  
 
The role of β-blockers on cardiac sympathetic innervation 
 While sympathetic hyperinnervation and hyperactivity after myocardial 
infarction are compensatory mechanisms to prevent heart failure due to loss 
of active myocardium, they have been shown to induce arrhythmias (Cao, et 
al., 2000b, Zhou, et al., 2001). Moreover, impaired cardiac functions in 
surviving individuals can lead to congestive heart failure (CHF), which is also 
characterized by hyperactivity of the sympathetic nervous system in an 
attempt to restore blood pressure (Ferrari, et al., 1998, Hunt, 2005). 
Therefore, after myocardial infarction, β-blockers are used to reduce a 
number of adverse effects including chest pain, arrhythmias and the 
probability of reinfarction and mortality (Yusuf, et al., 1985, Viskin, et al., 
1995). In addition, they are also used to decrease the effects of sympathetic 
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hyperactivity during CHF (Hunt, 2005). Therefore, we studied their role on 
cardiac innervation post-infarction and in uninjured hearts. While they are 
widely used, withdrawal from β-blocker has long been known to induce 
adverse effects including worsening of angina, myocardial infarction and 
ventricular dysrhythmias (Miller, et al., 1975, Mizgala, et al., 1976, Nattel, et 
al., 1979, Hoeks, et al., 2007). The adverse symptoms are thought to result 
mainly from receptor supersensitivity which begins a couple of days after 
withdrawal, peaks after 6 days and is followed by a progressive decrease for 
about a week until the response returns to control levels (Nattel, et al., 1979, 
Hedberg, et al., 1980). However our results, suggest that sympathetic 
innervation may contribute to those adverse effects. 
Additionally, adrenergic receptor activation has been shown to promote 
NGF synthesis in many cell types (Dal Toso, et al., 1988, Colangelo, et al., 
1998), therefore we studied whether β-adrenergic receptor activation 
promotes neuronal remodeling by modifying cardiac NGF production.  
 Collectively, the findings presented in this dissertation identify a 
selective method to downregulate NGF in the infarct border region, providing 
insights for a possible therapeutic approach. In addition we identified that β-
blocker treatment induces sympathetic sprouting which contibutes to 














CHAPTER 2. POSSIBLE FACTORS MODULATING SYMPATHETIC 
 HYPERINNERVATION FOLLOWING MYOCARDIAL INFARCTION 
a. ROLE OF SYMPATHETIC INNERVATION IN REGULATING 
VENTRICULAR NGF LEVELS 











The abrupt necrosis of the ventricle as the result of a thrombus, leads to an 
extensive tissue remodeling. Myocyte apoptosis triggers an inflammatory 
cascade which is characterized by the secretion of cytokines, chemokines 
and growth factors. The release of nerve growth factor (NGF) induces 
sympathetic sprouting at the infarct border region which can lead to 
arrhythmias and sudden cardiac death. The objective of this study was to 
identify potential ways to selectively reduce border region sympathetic 
hyperinnervation; first, by reducing cardiomyoctyes NGF synthesis via 
reduction of adrenoceptor activation, second, by reducing inflammation with 
dexamethasone. To induce chemical sympathectomy, rats were given 
guanethidine or saline injections. Sympathectomy was confirmed by 
immunohistochemical stainings. Ventricle NGF synthesis was determined by 
immunoblots, revealing that sympathectomy increased the 37 and 44kD 
proNGF isoforms in the lateral wall and in the base of the heart respectively 
compared to control heart samples, but total NGF proteins were unchanged 
between groups. Alternatively, rats received coronary artery ligation and were 
treated with dexamethasone or with saline for 7 days. Dexamethasone 
induced a significant weight loss compared to saline treated rats. Border 
region sympathetic innervation was quantified and no difference was found 
between groups. Together these results show that the modulation of cardiac 
NGF synthesis via adrenoceptors or the administration of dexamethasone 
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after infarction are strategies that fail to reduce sympathetic hyperinnervation. 
Future studies should target a more selective aspect of the neurotrophic 




  Infarct border region is associated with sympathetic hyperinnervation, 
which can lead to arrhythmias and sudden cardiac death (Cao, et al., 2000a, 
Cao, et al., 2000b, Chen, et al., 2001). Amongst many factors that are 
involved in the inflammatory cascade (Frangogiannis, 2004, Frangogiannis, et 
al., 2005), nerve growth factor (NGF) is a central neurotrophin causing 
sympathetic hyperinnervation after myocardial infarction (Zhou, et al., 2004, 
Hasan, et al., 2006). In explant studies, we found that border region infarcted 
tissue induced maximal sprouting from superior cervical ganglia at 7 days 
post-coronary artery ligation. Moreover, this outgrowth was suppressed by the 
addition of anti-NGF antibodies in the conditioned medium, suggesting that 
NGF is required for border region sympathetic hyperinnervation (Hasan, et 
al., 2006). Reducing NGF could therefore provide a decrease of sympathetic 
hyperinnervation leading to a reduced risk of developing arrhythmias after 
myocardial infarction. However, NGF is expressed by many cell types 
(Hasan, et al., 2000) including cardiomyocytes (Lockhart, et al., 2000) and 
inflammatory cells (Hasan, et al., 2006) and is important in a number of 
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physiological functions. Therefore, we studied different ways to promote 
downregulation of border region NGF.  
 
A. Role of sympathetic innervation in regulating ventricular NGF levels 
First, we studied if blocking β adrenergic receptors (AR) on 
cardiomyocytes at the border region could lead to the selective 
downregulation of NGF. The activation of β2-AR has been found to induce 
robust NGF expression in many cell types including fibroblasts and 
astrocytoma cells (Dal Toso, et al., 1988, Colangelo, et al., 1998). Because β-
AR are present on cardiomyocytes (Rohrer, et al., 1999, Devic, et al., 2001), 
downreguating the activation of these receptors may also reduce NGF 
expression. To reduce β-AR activation we first reduced their agonist, 
norepinephrine by inducing chemical sympathectomy with guanethidine and 
we quantified changes in ventricular NGF expression. 
 
B. Role of dexamethasone on border region sympathetic 
hyperinnervation 
 Inflammatory cells are a robust source of NGF in the border region 
(Hasan, et al., 2006), therefore reducing inflammation could selectively 
decrease NGF leading to a reduction of sympathetic hyperinnervation.  
 Dexamethasone is a synthetic glucocorticoid that is commonly used to 
reduce inflammation. Its reasonable cost and availability make it a good 
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candidate as a potential drug treatment. Dexamethasone mediates its action 
primarily by inhibiting phospholipase A2, leading the reduction of 
prostaglandin, thromboxane and leukotriene (Boyanovsky, et al., 2009). 
Besides these actions, it is also known to downregulate NGF production by 
peripheral organs which could lead to reduced sympathetic innervation 
(Lindholm, et al., 1994). However, it has been shown to promote neurite 
outgrowth of a neuronal cell line (Sheehan, et al., 2006). Therefore, we 
assessed the effect of dexamethasone treatment on border region 
sympathetic hyperinnervation.  
   
MATERIAL AND METHODS 
 
Guanethidine treatment 
Because cardiovascular disease is more prevalent in post-menopausal 
women (Lloyd-Jones, et al., 2009), twelve female Sprague Dawley rats 
(Harlan Breeding Laboratories; Indianapolis, IN) were obtained at 60 days of 
age (~200g), housed 2-3 per cage in a climate and light (12L:12D) controlled 
environment with food and water ad libitum. All experimental protocols 
conformed to NIH guidelines and were approved by the University of Kansas 
Medical Center Animal Care and Use Committee.  
Rats were anesthetized by intraperitoneal injection of KAX (i.p. 
injection of 60 mg/kg ketamine HCl Keta-Ject, Phoenix Scientific, St. Joseph, 
MO; 0.4 mg/kg atropine sulfate, Healthcare corporation, Deerfield, IL; 8 mg/kg 
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xylazine Xyla-Ject, Phoenix Scientific, St. Joseph, MO) and ovaries were 
removed by flank incisions (Zoubina, et al., 2002). A week later, six rats were 
given intraperitoneal injections of 25mg/kg guanethidine in saline solution 
twice a day at least 10 hours apart and six rats were given saline injections, at 
that same time. After ten days, rats were anesthetized as above and hearts 
were harvested.  
For immunohistochemistry analysis, hearts were embedded in Tissue 
Freezing Medium (Triangle Biomedical Sciences, Durham, NC) and snap 
frozen in isopentane cooled in liquid nitrogen and stored at -80ºC (N=2 per 
group). For western blots analysis, the base and the lateral wall of the heart 
were dissected into 3mm2 samples (N=4 per group). Samples were 
homogenized in 200μl RIPA lysis buffer (Chemicon, Temecula, CA) with 10% 
protease inhibitor (Sigma, St. Louis, MO) and 1% phosphatase inhibitor 
(Sigma, St. Louis, MO) using Metal Rotor Stator Generator probes.  
 
Innervation assessment after guanethidine 
 Hearts were cryosectioned serially at 10 μm thickness perpendicular to 
the apical-basal axis. Sections were fixed in 4% paraformaldehyde, blocked 
with normal goat serum supplemented with 1% bovine serum albumin, and 
immunostained overnight for the selective sympathetic axon markers 
dopamine β-hydroxylase (DBH, 1:200, rabbit IgG, Immunostar, Hudson, WI), 
or vesicular monoamine transporter 2 (VMAT2, 1:100, rabbit IgG, Chemicon, 
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Temecula, CA)  followed by a 2 h incubation in goat anti-rabbit IgG 
conjugated to cy3 (1:100, Jackson Immunoresearch Laboratories, West 
Grove, PA). Images were captured with a 40x objective using a Nikon Eclipse 
TE300.  
 
NGF western blots 
 Proteins were separated by SDS-PAGE (Invitrogen, Carlsbad, CA) and 
transferred to polyvinylidene difluoride membranes. Membranes were blocked 
with 5% nonfat dry milk in TBST (10mM Tris HCl, 150mM NaCL, pH 7.4 and 
0.05% Tween solution-20) followed by overnight incubation at 4ºC in 1:1000 
rabbit anti-NGF (Santa Cruz Biotechnology, Santa Cruz, CA) in TBS and in 
goat anti-rabbit 1:5000 AP-conjugated (Jackson, West Grove, PA). 
Immunoreactive proteins were detected using Immunostar substrate (BioRad, 
Hercules, CA) and visualized using a ChemiDoc XRS (BioRad, Hercules, 
CA). NGF proteins were normalized to total protein, which was determined by 
incubating the membranes in 7% acetic acid, 10% methanol and floated in 
SYPRO Ruby stain reagent (Molecular Probes, Carlsbad, CA). Proteins were 








Within a week of arrival, seven rats were anesthetized with KAX as 
above and ovariectomized (Zoubina, et al., 2003). A week later, rats were 
reanesthetized, respired mechanically, and the  left anterior descending 
coronary artery was ligated with a silk suture (Hasan, et al., 2006). Rats 
received daily injections of 2mg/kg/day dexamethasone (Spectrum, Gardena, 
CA) in saline (N=4) or injections of saline alone (N=3). After seven days, rats 
were anesthetized and hearts were harvested and snap-frozen as above.  
 
Infarct size 
Due to variation in the vasculature, obstruction of a coronary artery can 
result in variable infarct size. Thus, this study was designed to eliminate any 
effects caused by variability of infarct extension.  
To establish infarcts physical dimensions, one set of 6 sections taken 
at ~2mm intervals through the entire ventricle was stained with Masson’s 
Trichrome (Diagnostic BioSystems, Pleasanton, CA).  Sections were fixed for 
10 minutes in 4% paraformaldehyde and 20 minutes at 50 ºC in Bouin’s 
solution (Electron Microscopy Sciences, Hatfield, PA). Sections were 
incubated in Weigert’s iron hematoxilin, biebrich scarlet-acid fuchsin, 
phosphomolybdic-phosphotungstic acid and aniline blue. Images of the infarct 
were captured using a Nikon SMZ 1500 microscope with a 1x objective at 
0.75 optical zoom, and the area of the infarction was measured (AnalySis, 
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Soft Imaging System), multiplied by the distance between sampled sections, 
and these values summed to provide an estimate of the infarct size for each 
heart.  
 
Sympathetic innervation after dexamethasone treatment 
 Adjacent to Masson’s Trichrome sections, six sections were fixed at 
4ºC in methanol for 10 min, blocked with normal goat serum supplemented 
with 1% bovine serum albumin and stained overnight for dopamine-β-
hydroxylase (DBH: 1:600, rabbit IgG, Immunostar, Hudson, WI). Secondary 
antibody goat anti-rabbit IgG conjugated to Alexa 555 (1:500, Invitrogen, 
Carlsbad, CA) was applied for 2 h. Images of 6 fields evenly distributed in the 
border region located in the left lateral posterior area of the heart were taken 
with a 40x objective using a Nikon Eclipse TE300. Nerve density was 
calculated by superimposing a stereological grid (8μm line interval) over the 
captured image, counting grid intersections over nerves and dividing by the 
total number of intersections over the sampled tissue.  
 
Statistical Analyses 
Data were analyzed using Student T-test (SigmaStat 3.11, Systat Software, 
Inc., San Jose, CA). Data are expressed as mean ± SEM. Statistical 






Effects of sympathectomy 
 To confirm that guanethidine treatment induced chemical 
sympathectomy, sections were stained with two sympathetic neuronal 
markers, DBH and VMAT2. Control hearts displayed sympathetic fibers 
running along cardiomyocytes with both DBH-ir (Fig. 1A) and VMAT2-ir (Fig. 
1C) and guanethidine suppressed sympathetic innervation visible by a 
marked reduction of both DBH-ir (Fig. 1B) and VMAT2-ir (Fig. 1D). 
 Six bands were visible on immunoblots of NGF from heart samples 
with molecular weights of 73, 44, 37, 25, 23 and the mature isoform at 14kD 
(Fig. 2A). Sympathectomy increased the 37kD NGF isoform by 34% in the 
lateral wall of the heart relative to control (from 1.1±0.04 *10-2 after saline to 
1.48±0.08 *10-2 INT*mm2 after guanethidine). However, total NGF proteins 
were unchanged in that region (7.52±1.20 *10-2 INT*mm2 and 7.99±0.82 *10-2 
INT*mm2 after saline and guanethidine, respectively). Similarly, the 44kD 
NGF isoform was increased by 67% in the base of the heart after 
sympathectomy relative to control (from 0.36±0.042 *10-2 INT*mm2 after 
saline to 0.61±0.089 *10-2 INT*mm2 after guanethidine). However, 
sympathectomy did not modify total NGF protein in that region of the heart 






Effect of dexamethasone  
 To confirm that the administered dose of dexamethasone had a 
significant effect, we monitored rat weight, as previously reported treatment 
with dexamethasone reduced total body weight compared to controls 
(Shafagoj, et al., 1992). During seven days, control rats gained 15 ± 3 g, while 
dexamethasone treatment induced a weight loss of 29 ± 5 g (Fig 3). To 
eliminate a non-specific effect of the treatment on sympathetic innervation 
caused by variation of infarct extension, we insured that infarct size was 
comparable between groups. Following the exclusion of one heart from the 
saline group due to the lack of transmural infarct, infarct sizes were 114 ± 5 
mm3 in controls and 104 ±19 mm3 after dexamethasone treatment (Fig. 4). 
Border region sympathetic hyperinnervation was similar to our previous 
findings (Wernli, et al., 2009) and was unchanged after dexamethasone 




 Thrombus in a coronary artery can result in ischemia followed by 
necrosis of the supplied ventricular tissue (Fishbein, et al., 1978, 
Frangogiannis, 2006). Cardiomyocyte apoptosis triggers a complex 
inflammatory cascade (Frangogiannis, et al., 2002). Recruited inflammatory 
cells promote cellular differentiation and proliferation (Garaci, et al., 1999, 
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Micera, et al., 2003) by secreting a number of factors including nerve growth 
factor (NGF). Besides contributing to wound repair (Li, et al., 1980), NGF 
promotes sympathetic neuronal sprouting (Levi-Montalcini, 1987, Hasan, et 
al., 2006). Excessive norepinephrine released by these axons at the infarct 
border region can induce arrhythmias (Cao, et al., 2000b). As a result, the risk 
of sudden cardiac death is increased (Cao, et al., 2000a). Therefore, in the 
present study, we evaluated two possible ways to reduce border region 
sympatheitic hyperinnervation.  
 
A. Role of sympathetic innervation on ventricular NGF levels 
Sympathetic innervation releases norepinephrine, which activates 
adrenergic receptors. Since, the activation of β-AR increases NGF synthesis 
in various cell types (Dal Toso, et al., 1988, Colangelo, et al., 1998), this 
implies that by reducing their activation in the heart, border region NGF may 
be decreased. In order to reduce cardiac adrenergic receptor activation, we 
induced chemical sympathectomy with guanethidine.  
We found that chemical sympathectomy increased the 37kD and 44kD 
proNGF isoforms in the lateral wall and the base of the heart respectively 
while mature NGF was hardly visible. Because proNGF isoforms tend to be 
pro-apoptotic (Lee, et al., 2001, Fahnestock, et al., 2004) and mature NGF 
appeared absent, this suggests that a positive feedback loop may take place 
further depleting innervations in those regions. Conversely, sympathetic 
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innervation may be enhanced and could thus contribute to border region 
hyperinnervation. Nonetheless, total NGF was unchanged in both areas.  
Although transcription and translation may be increased by 
sympathectomy, because specific isoforms are upregulated, it is more 
probable that the increase of pro-NGF reflects changes in post-translational 
processing. NGF is subject to a number of post-translational modifications 
including sulfonation, glycosylation and cleavage (Lee, et al., 2001, Boutilier, 
et al., 2008); it is therefore possible that changes of norepinephrine activation 
of adrenergic receptors on cardiomyoctyes modifies some of those 
intracellular pathways. The activation of β1-adrenergic receptors on 
cardiomyocytes results in the activation of the Gs protein followed by the 
production of the second messenger cAMP (Wang, et al., 2004) and by the 
activation of protein kinase A (Lefkowitz, 2004). This cascade provokes 
calcium influx leading to increased force of contraction. In addition, Gs protein 
activation can also lead to a number of other intracellular pathways (Selbie, et 
al., 1998). Activation of these pathways may converge on NGF synthesis, 
thereby modifying the level of production of its isoforms. Alternatively, 
degradation may be reduced by these intracellular modifications leading to 
the increase of some pro-NGF isoforms.  
Sympathectomy has been shown to induce changes of NGF 
expression in cardiac ganglia, supporting the fact that sympathetic neurons 
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modulate NGF intracellular pathways of other cell types in the ventricle 
(Hasan, et al., 2009).  
The depletion of sympathetic innervation induces complex responses 
and has been shown to modulate NGF levels is some models but not in 
others. For example, surgical denervation significantly reduced NGF in the 
mesenteric artery (Liu, et al., 1996) suggesting that the decrease of NGF was 
caused by the loss of nerve plexus (Liu, et al., 1996). In another study, 
ciliarectomy and sympathectomy did not modify NGF levels in the iris while 
denervation including all sensory axons induced an increase of NGF levels 
(Ebendal, et al., 1983), suggesting that sensory neurons regulate NGF in that 
environment. Finally, chemical sympathectomy induced by 6-
hydroxydopamine for one week after birth reduced norepinephrine content by 
82% but did not significantly alter NGF mRNA in the heart (Clegg, et al., 
1989).   
Together, the absence of change of total NGF in the ventricle after 
removing sympathetic nerves suggests that border region cardiomyocytes 
may not contribute to reducing sympathetic hyperinnervation following 
myocardial infarction. Therefore, reducing inflammation may provide a better 





B. Role of dexamethasone on border region sympathetic 
hyperinnervation 
Dexamethasone is a member of the glucocorticoid family, which is 
extensively used for its anti-inflammatory, immunosuppressive and 
antiproliferative functions (Verderame, 1986). Anti-inflammatory steroids are 
administered to treat a wide variety of conditions including arthritis, dermatitis, 
autoimmune diseases, asthma or to prevent rejection of organ transplant. 
However, because they interact with the naturally occurring adrenal steroids, 
which regulate electrolyte balance and glucose metabolism, they can cause 
many adverse effects. Notably, prolonged use can provoke muscle weakness 
and degeneration, osteoporosis, inhibition or arrest of growth in children, skin 
fragility and atrophy, hyperglycemia or cataract (Verderame, 1986).  
Following myocardial infarction, inflammatory cells are recruited to 
repair the ischemic area. During this process, NGF levels are upregulated 
leading to sympathetic hyperinnervation. Because in addition to its anti-
inflammatory properties, dexamethasone is known to reduce NGF levels in 
peripheral organs (Lindholm, et al., 1994), we studied its effect on border 
region sympathetic innervation.  
We found that the dexamethasone dose administered caused a 
significant weight loss, consistent with previous findings (Shafagoj, et al., 
1992); however, our results demonstrated that infarct border region 
hyperinnervation was unchanged by dexamethasone treatment.   
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Contrary to our findings, a study found a significant reduction in 
neurofilament M-ir fibres in the infarct associated with a decrease of NGF (El-
Helou, et al., 2007). There may be several reasons for the discrepency, such 
as drug dosage or methodological procedures; in that study, infarct size was 
not reported to be identical between the two groups, moreover quantification 
was the result of two random sections per animal. Finally neurofilament M-ir 
stains many neuronal populations and it is therefore not selective for 
sympathetic fibers. 
The failure of dexamethasone to attenuate symapthetic innervation in 
our study is most likely a result of its pluripotent and sometimes contradicting 
action. Thus, in spite of the anti-inflammatory properties of dexamethasone 
which could reduce infarct inflammation and NGF production, dexamethasone 
has been shown to potentiate neurite outgrowth in vitro and to be associated 
with increased neuronal recovery after spinal cord injury (Sheehan, et al., 
2006). Moreover, dexamethasone was found to enhance macrophage colony 
stimulating factor (M-CSF), which is the major growth factor controlling 
survival, proliferation and differentiation of macrophages (Lloberas, et al., 
1998) and could therefore enhance macrophage NGF production in the 
border region (Hasan, et al., 2006). The conflicting actions of dexamethasone 
on neuronal outgrowth could thus explain the lack of a decrease of 




In spite of the adverse effects induced by synthetic glucocorticoids they 
remain highly useful to treat clinical disease. Moreover, nonsteroidal anti-
inflammatory drugs (NSAID) can also cause problems such as ulceres, 
edema, kidney failure or renal failure. Additionally, the COX-2 inhibitor sold by 
Merck under the name Vioxx which was thought to have potent analgesic and 
anti-inflammatory properties, was found to increase the risk of myocardial 
infarction (Warner, et al., 2008).  
Thus, reducing inflammation has proven to be difficult as drug 
treatments can have generalized actions leading to secondary adverse 
effects. For this reason, the development of anti-inflammatory drugs will 
certainly become more refined to target a specific aspect of the inflammatory 
cascade. As an attempt to refine our strategy to reduce border region 
sympathetic hyperinnervation, we used clodronate liposomes in our next 
study to selectively deplete macrophages.  
 
Conclusion 
Collectively these results show that the inflammatory cascade induced 
to repair the necrotic tissue after coronary obstruction promotes robust 
sympathetic sprouting. Depleting sympathetic innervation leads to the 
alteration of some post-translational NGF isoforms, but total NGF remains 
unchanged between groups. Therefore, modifying the crosstalk between 
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sympathetic innervation and cardiomyocyte may not be the best target to 
decrease sympathetic hyperinnervation.   
 On the other hand, reducing the inflammation with dexamethasone did 
not affect hyperinnervation either. While dexamethasone is extensively used 
for its anti-inflammatory, immunosuppressive and antiproliferative functions, 
its actions are broad and can be conflicting, explaining the absence of change 
of innervation. Future studies will need to use a more selective anti-
inflammatory approach in order to reduce NGF and sympathetic 








































Figure 1. The reduction of sympathetic innervation after guanethidine 
treatment is reflected by multiple markers. Sections from control hearts were 
immunostained for the noradrenergic markers DBH (A) and VMAT2 (C) and 
sympathetic fibers are running along cardiomyocytes. After guanethidine 
treatment, DBH (B) and VMAT2 (D) were reduced showing that the treatment 

































Figure 2. Effect of guanethidine on ventricular NGF levels. A shows that at 
least six NGF isoforms are present in the lateral wall of the heart and that 
guanethidine treatments increases synthesis of the 37kD isoform (box). 
Quantitative analysis of the 37kD NGF isoforms (B) and of total NGF protein 
(C). D, shows that the same isoforms are present in the base of the heart and 
that the synthesis of the 44kD isoform (box) is increased in that region. 

























Figure 3. Effect of dexamethasone on weight. Treatment for 7 days post-
infarction with dexamethasone induced weight loss while control rats given 




























Figure 4. Infarct size of rats given dexamethasone or saline. To insure that 
sympathetic innervation was not influenced by a variation of infarct extension, 
infarct size was measured and was comparable after dexamethasone and 




























Figure 5. Effect of dexamethasone on border region sympathetic innervation 
density. Sympathetic innervation was quantified in the border region of six 
equally spaced sections. These regions were hyperinnervated in both groups 
and dexamethasone treatment did not influence sympathetic innervation 























CHAPTER 3. MACROPHAGE DEPLETION SUPPRESSES SYMPATHETIC 
















Myocardial infarction induces sympathetic axon sprouting adjacent to the 
necrotic region, and this has been implicated in the etiology of arrhythmias 
resulting in sudden cardiac death. Previous studies showed that nerve growth 
factor (NGF) is essential for enhanced post-infarct sympathetic sprouting, but 
the cell types necessary to supply this neurotrophic protein are unknown.  
The objective of the present study was to determine whether macrophages, 
which are known to synthesize NGF, are necessary for post-infarct cardiac 
sympathetic sprouting.  Ovariectomized female rats received left coronary 
artery ligation or sham operation, followed by intravenous injection of 
liposomes containing saline vehicle or clodronate, which kills macrophages. 
Sham-operated myocardium contained some sympathetic axons, few 
myofibroblasts and T-cells and no CD-68-positive macrophages. In rats 
receiving saline liposomes through 7 days post-ligation, the posterolateral 
infarct border contained numerous myofibroblasts, macrophages and T-cells, 
and sympathetic innervation at the border region was increased two-fold. 
Treatment with clodronate liposomes reduced macrophage numbers by 69%, 
while myofibroblast area was reduced by 23% and T-cell number was 
unaffected.  Clodronate liposome treatment reduced sympathetic axon 
density to levels comparable to the uninfarcted heart. NGF protein content 
measured in western blots was reduced to 33% of that present in infarcts 
where rats received saline-containing liposomes. Tissue morphometry 
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confirmed that NGF immunostaining was dramatically reduced, and this was 
attributable primarily to reduced macrophage content.  These results show 
that macrophage destruction markedly reduces post-infarction levels of NGF 
and that the presence of elevated numbers of macrophages is obligatory for 
development of sympathetic hyperinnervation following myocardial infarction. 
 
Key words: Myocardial infarction, sympathetic hyperinnervation, 




Sudden cardiac death is a major clinical problem, accounting for more 
than 300,000 deaths annually in the United States (Myerburg, et al., 1992b). 
The risk of sudden cardiac death is especially high after myocardial infarction 
(MI) as 75% of victims have had a previous MI (Myerburg, et al., 1992a), 
generally in the 30 days prior to death (Solomon, et al., 2005). The direct 
cause of sudden cardiac death is most often ventricular tachycardia leading to 
ventricular fibrillation (Cao, et al., 2000a). Although the etiology of these post-
MI ventricular arrhythmias remains incompletely understood, an increase in 
sympathetic nerve density at the infarct border zone has been implicated 
(Cao, et al., 2000b). We and others have shown that sympathetic 
hyperinnervation peaks 7 days after occlusion of the left coronary artery and 
decreases gradually through 28 days post-MI in rodents and dogs (Zhou, et 
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al., 2004, Hasan, et al., 2006) and this time course is consistent with the 
highest risk of sudden cardiac death observed clinically in humans (Solomon, 
et al., 2005).  
Several lines of evidence suggest that nerve growth factor (NGF), a potent 
sympathetic neurotrophic protein (Levi-Montalcini, 1987), may play a role in 
post-MI sympathetic sprouting (Zhou, et al., 2004, Chen, et al., 2007). In 
explant cultures of infarcted tissue, NGF antibody neutralization blocked 
neurite outgrowth from sympathetic ganglia, demonstrating that NGF is 
required for development of sprouting at the infarct border zone (Hasan, et 
al., 2006). Similarly, in vivo studies where synthetic glucocorticoids were 
administered following MI showed reductions in infarct border zone 
sympathetic hyperinnervation (El-Helou, et al., 2007), and it is well 
established that these hormones generally suppress NGF production 
(Lindholm, et al., 1994). Accordingly, NGF synthesis within the infarcted 
region is likely to play a causal role in inducing local sympathetic sprouting.  
Despite evidence that NGF synthesis is required for sympathetic 
hyperinnervation, the cellular mechanisms leading to elevated NGF synthesis 
following myocardial infarction remain unclear. In the normal rat heart, 
sympathetic innervation density correlates with NGF mRNA levels (Shelton, 
et al., 1984) suggesting that NGF upregulation in cardiac myocytes after 
injury could be a contributing factor.  However, the border zone between 
damaged and intact myocardium also contains increased numbers of 
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macrophages and myofibroblasts (Hasan, et al., 2006).  Wounds such as 
those created by ischemic injury are characterized by an influx of 
macrophages deriving from vascular monocytes that assist healing by 
phagocytosing cellular debris and secreting a variety of cytokines and growth 
factors. Cytokines present in inflammatory environments are known to 
promote activation of macrophages (Adams, et al., 1984) and in vitro 
macrophage activation induces NGF expression (Caroleo, et al., 2001), 
suggesting that macrophages could contribute to sympathetic 
hyperinnervation. Myofibroblasts are thought to transdifferentiate from 
fibroblasts, pericytes, and possibly macrophages (Schmitt-Graff, et al., 1994, 
Hasan, et al., 2000), and to promote wound healing through contraction and 
collagen deposition. Myofibroblasts, as well as another inflammatory wound 
cell, the T-cell, are also known to synthesize NGF  (Hasan, et al., 2006), 
making them possible contributors to the induction of sympathetic 
hyperinnervation.  
In the present study, we assessed the role of macrophages in the 
development of post-MI sympathetic hyperinnervation.  We administered 
clodronate-containing liposomes, which are phagocytosed by macrophages 
and cause selective macrophage apoptosis and depletion (van Rooijen, et al., 
1996). Our findings show that reductions in the macrophage population 




MATERIAL AND METHODS 
 
Experimental Preparations 
All experimental protocols conformed to NIH guidelines and were 
approved by the University of Kansas Medical Center Animal Care and Use 
Committee. Thirty-three female Sprague-Dawley rats (60 days old, ~ 200 g, 
Harlan Breeding Laboratories) were anesthetized by intraperitoneal injection 
of 60 mg/kg ketamine, 8 mg/kg xylazine, and 0.4 mg/kg atropine. To minimize 
the influence of reproductive hormones and also to simulate postmenopausal 
conditions which are associated with reduced cardioprotective effects 
(Kannel, et al., 1976, Grace, et al., 2004), ovaries were removed by flank 
incisions (Zoubina, et al., 2001). Seven days after ovariectomy, rats were 
anesthetized as above, respired mechanically, and the left anterior 
descending coronary artery was ligated with silk suture as described 
previously (Selye, et al., 1960, Hasan, et al., 2006). In sham surgeries, a 
suture was passed around the artery but left untied.  Following coronary 
artery ligation (CAL) or sham-ligation, rats received tail vein injections on days 
1, 3, and 5 of liposomes containing clodronate (Popovich, et al., 1999) or 
phosphate-buffered saline, or normal saline (1ml/100 g body weight). 
Clodronate was a gift from Roche Diagnostics GmbH, Mannheim, Germany 
(Van Rooijen, et al., 1994).  
Seven days after coronary artery ligation, rats were reanesthetized as 
above and hearts were harvested. The efficacy of the ligation in producing 
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ventricular infarction was confirmed in preliminary observations by immersion 
in 1% triphenyl tetrazolium chloride (TTC) in phosphate buffer for 30 minutes 
at 40ºC followed by fixation in formal saline (Lie, et al., 1975).  Other hearts 
were harvested, embedded in tissue freezing medium (Triangle Biomedical 
Sciences, Durham, NC) and snap frozen in isopentane cooled in liquid 
nitrogen and stored at -80ºC.  
 
Infarct Assessment 
  Because of anatomical variation in coronary arterial vasculature, 
ischemic damage was variable and was more limited in some hearts than in 
others.  To ensure that analyses were conducted on specimens with 
comparable damage in all groups, infarcts that did not span the entire 
thickness of ventricular wall or only partially affected the left ventricle were 
excluded from further study. The numbers of infarctions excluded in each 
group was 2 of 7 (28%) in the saline liposome group, 1 of 7 (14%) in the 
saline injected group, and 4 of 11 (36%) in the clodronate liposome treatment 
group.  
Hearts were cryosectioned serially at 10 μm thickness perpendicular to 
the apical-basal axis. To establish the physical dimensions of infarcts, one set 
of 6 sections taken at 1.7 mm intervals through the entire ventricle was 
stained with Masson’s Trichrome according to a standard protocol (Diagnostic 
BioSystems, Pleasanton, CA).  Sections were fixed for 10 minutes in 4% 
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paraformaldehyde and 20 minutes at 50 ºC in Bouin’s solution (Electron 
Microscopy Sciences, Hatfield, PA).  Images of infarcts were captured using a 
Nikon SMZ 1500 microscope with a 1x objective at 0.75 optical zoom, and the 
area of the infarction was measured (AnalySis, Soft Imaging System, 
Lakewood, CO), multiplied by the distance between sampled sections, and 
these values summed to provide an estimate of the infarct size for each heart.  
 
Sympathetic Innervation  
To assess sympathetic innervation density, we analyzed four sections 
adjacent to the Masson’s trichrome-stained set; the first section for analysis 
was taken 1.5 to 2 mm apical to the ligation, which ensured that we did not 
include tissue with local inflammation due to the ligation. Sections were fixed 
at 4ºC in methanol,  blocked with normal goat serum, and immunostained 
overnight for the selective sympathetic axon marker dopamine β-hydroxylase 
(DBH, 1:600, rabbit IgG, Immunostar, Hudson, WI), followed by a 2 h 
incubation in goat anti-rabbit IgG conjugated to Alexa 555 (1:500, Invitrogen, 
Carlsbad, CA).  For each section, 6 fields evenly distributed within the left 
lateral posterior aspect of the infarct were captured with a 40x objective using 
a Nikon Eclipse TE300 (indicated by boxes in Fig 1.A and C); preliminary 
observations showed sympathetic innervation associated with the infarcted 
tissue was preferentially distributed within this region. In sham hearts, images 
were taken in an identical fashion from comparable areas. Nerve density was 
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calculated by superimposing a stereological grid (8μm line interval) over the 
captured image, counting grid intersections over nerves and dividing by the 
total number of intersections over the sampled tissue (Zoubina, et al., 1998, 
Zoubina, et al., 2001). Vascular innervation was excluded from quantification. 
To confirm that the changes observed with the quantification of DBH were not 
caused by changes of the level of that enzyme alone, adjacent sections to the 
ones stained for DBH were fixed in 4% paraformaldehyde for 5 minutes, 
blocked with normal goat serum, and immunostained overnight for the 
intermediate filament marker peripherin (1:1000, chicken IgG, Chemicon, 
Temecula, CA) followed by a 2 h incubation with goat anti-chicken IgG 
conjugated to cy2 (1:200, GeneTex, San Antonio, TX). Another set of 
adjacent  sections was fixed in 4% paraformaldehyde for 5 minutes, blocked 
with normal goat serum, and immunostained overnight for the selective 
sympathetic axon marker tyrosine hydroxylase (TH, 1:300, rabbit IgG, 
Chemicon, Temecula, CA) followed by a 2 h incubation in goat anti-rabbit IgG 
conjugated to cy3 (1:400, Jackson, West Grove, PA). 
 
Inflammatory Cells  
A second set of sections adjacent to the DBH-immunostained series was 
stained for CD68 (1:200, mouse monoclonal, MAB 1435, Chemicon, 
Temecula, CA), a marker for tissue macrophages and blood monocytes 
(Micklem, et al., 1989).  A third set was stained for  α-smooth muscle actin 
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(1/200, mouse monoclonal 1A4, Sigma, St. Louis, MO), which identifies 
myofibroblasts (Skalli, et al., 1986, Hasan, et al., 2000). A fourth set of 
adjacent sections was immunostained for the T-cell antigen receptor TCR α/β 
(1:100, mouse monoclonal, clone R73, Serotec, Oxford, UK).  All 
inflammatory cell markers were co-stained with rabbit IgG recognizing rat 
NGF (1:100, M-20, Santa Cruz, Santa Cruz, CA). Secondary antibodies were 
Alexa 488-conjugated goat anti-mouse (1:1000 Invitrogen, Carlsbad, CA) and 
Alexa 555-conjugated goat anti-rabbit (1:500 Invitrogen, Carlsbad, CA). 
Antibody specificities were confirmed using antigen preadsorbtion with a 10 
fold excess of the peptide and primary antibody omissions.  
Macrophage, myofibroblasts and T-cells were quantified by capturing 4 
images with a 40x objective on a Nikon Eclipse C1 Si confocal microscope 
from each stained section in the same areas as those used for innervation 
assessment. To quantify macrophages, numbers of CD68-immunoreactive (ir) 
cells per field were counted and expressed as the average number of cells 
per mm2 (Metamorph, Molecular Devices, Downingtown, PA).  In addition, 
average macrophage size was estimated by measuring total section area 
occupied by CD68-ir by threshold detection and dividing it by the total number 
of CD68-ir macrophages. Because myofibroblasts form sheet-like aggregates 
within the infarct, counting individual cells is not feasible. Therefore, 
myofibroblasts were quantified by measuring the area per field occupied by α-
SMA-ir cells, taking care to exclude α-SMA-ir vascular smooth muscle; the 
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percentage of field area was assessed by counting stereological grid 
intersections overlying myofibroblasts, dividing this by total number of 
intersects within that field, and expressing this as area per mm2 (AnalySis, 
Soft Imaging System, Lakewood, CO). T-cells associated with the infarct were 
assessed by counting TCR α/β-ir cells per each of the 4 fields and expressed 
as the average numbers of cells per mm2.  
 
NGF and Cytokine content 
The content of NGF protein in infarct tissue was quantified by western 
blots. Infarcted hearts from 3 saline liposome and 4 clodronate liposome rats 
were snap frozen and the border region with adjacent intact myocardium was 
dissected out and homogenized in Ripa buffer (50mM TrisHCl pH 7.4, 150mM 
NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1mM EDTA) with 10% 
protease inhibitor (Sigma, St. Louis, MO) and 1% phosphatase inhibitor 
(Sigma, St. Louis, MO). Fifty μg of protein was loaded on a gel and western 
blot was performed according to protocol (Invitrogen, Carlsbad, CA). The 
membrane was stained overnight with rabbit anti-NGF (1:500,Santa Cruz, 
Santa Cruz, CA) in 5% goat serum and 2hr in goat anti-rabbit HRP (1:5000, 
Sigma, St. Louis, MO). After revealing the bands with SuperSignal West Pico 
Stable Peroxide Solution (Thermo Sc., Rockford, IL), their intensities were 
analyzed using a Chemi Doc XRS and quantification was performed using 
Quantity One software (BioRad, Hercules, CA). Total protein stained with 
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India ink was used to verify that equal amount of proteins were loaded on the 
gel and transferred to the membrane. The total density assessed by India ink 
was constant between samples and was used to normalize the density of the 
NGF bands.   
The contribution of each cell type to the NGF content within the infarct was 
assessed in samples co-stained for the cell-selective markers and for NGF. 
For both CD68-ir and TCRα/β-ir cells, numbers of cells co-expressing both 
proteins were counted in each of the 4 sample regions and normalized to 1 
mm2. In addition, for both markers the total field area occupied by NGF-
ir/CD68-ir macrophages and NGF-ir/ TCRα/β-ir T-cells was measured by 
threshold detection (Metamorph, Molecular Devices, Downingtown, PA) and 
the average area for the 4 fields expressed as μm2/mm2. The contribution of 
myofibroblasts to NGF expression within the infarct was assessed by 
superimposing a stereological grid (30μm line interval, AnalySis, Soft Imaging 
System, Lakewood, CO) over captured images and counting intersections 
overlying regions of NGF/α-SMA-ir colocalization  (i.e. yellow in merged 
images), dividing by the total number of sample area intersections, and 
normalizing to 1mm2.  
The effect of clodronate liposomes on the infarct content of mRNA 
encoding the inflammatory cytokines interferon-γ (IFN-γ), tumor necrosis 
factor-α (TNF-α) and macrophage chemotactic protein-1 (MCP-1) was 
evaluated in the samples obtained from the same specimens used for NGF 
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western blot analysis. Dissected regions were homogenized in ice cold trizol 
and total RNA (1μg) reverse transcribed using the iScript kit (Biorad, 
Hercules, CA). Amplification of cDNA was conducted using specific primers 
for IFN-γ, TNF-α, MCP-1 and GAPDH. Conditions for the PCR were 94ºC for 
40 s, 60ºC, 57ºC, 53.7 ºC and 60ºC for 30s, and 72ºC for 1 min for 30, 32, 31 
and 28 cycles respectively for IFN-γ, TNF-α, MCP-1 and GAPDH, with a final 
extension at 72ºC for 5min. The primers were 5’-
ATGGATGCTATGGAAGGAAAG-3’ (sense) and 5’-
TATTGGCACACTCTCTACCC-5’ (antisense) for IFN-γ; 5’-
CTTATCTACTCCCAGGTTCTC-3’ (sense) and 5’-
ACTTCAGCATCTCGTGTG-3’ (antisense) for TNF-α; 5’-
ACTCATTCACTGGCAAGATG-3’ (sense) and 5’-
GGTCAAGTTCACATTCAAAGG-3’ (antisense) for MCP-1; 5’-
CTCTACCCACGGCAAGTTC-3’ (sense) and 5’-CTCAGCACCAGCATCACC-
3’ (antisense) for GAPDH. Five microliters of PCR product was analyzed by 
electrophoresis (1.5% agarose gel with ethidium bromide). Bands were 
visualized under UV transillumination using a Chemi Doc XRS and quantified 








Data are expressed as mean ± SEM.  Data were analyzed using one way 
ANOVA followed by a Student-Newman-Keuls test or Student T-test 
(SigmaStat 3.11, Systat Software, Inc., San Jose, CA). Statistical significance 
was accepted at P<0.05.  No statistically significant differences were evident 
in any of the measurements obtained from groups receiving CAL followed by 
saline or by saline-containing liposomes, and these groups were therefore 
pooled into a single ‘saline’ group for subsequent analyses. 
 
RESULTS 
Infarct characterization  
No post-operative deaths occurred in the sham-ligated subjects (N=4 
in each sham group), while mortality was 21% (3/14) in the group receiving 
CAL plus saline and 27% (3/11) in the group receiving CAL plus clodronate 
liposomes. Characterization of the infarct by TTC and light microscopic 
analysis showed that left coronary artery ligation consistently produced an 
extensive area of necrosis that was confined to the left ventricle with minimal 
septal or right ventricular involvement (Fig. 1). Following exclusion of hearts 
that did not meet the transmural and size criteria, infarcts occupied 38.7 ± 
4.5% of the left ventricle in the saline CAL group and 42.3 ± 10.1 % of the left 





Innervation and inflammatory cell composition of uninjured hearts 
Ventricular tissue from rats receiving a sham ligation displayed 
morphological features similar to those we have reported previously for 
control animals (Hasan, et al., 2006). DBH-ir nerves were sparse (Fig. 2A) 
and present mainly in association with ventricular cardiomyocytes and 
vasculature. Quantitative analysis showed that DBH-ir sympathetic 
innervation occurred with a density of 0.84 ± 0.07% throughout the 6 
ventricular sample regions. In rats with a sham ligation, treatment with 
clodronate liposomes had no effect on DBH-ir sympathetic innervation density 
relative to saline controls (Fig. 2A, D).  
 In sections apical to the untied ligature, essentially no CD68-ir 
macrophages were observed (Fig, 2E, H).  We occasionally encountered α-
SMA-ir cells resembling myofibroblasts but their incidence was low (Fig. 2I, 
L).  Similarly, TCR α/β-ir T cells were encountered infrequently (Fig. 2M, P).   
 
Effect of infarction on innervation and inflammatory cell composition  
Seven days following CAL, DBH-ir sympathetic axon density at the border 
region of the infarct was increased 2-fold relative to that of control ventricular 
tissue (Fig. 2B, D). Consistent with previous findings (Hasan, et al., 2006), 
this was associated with a dramatic increase in macrophage density to about 
1,200 cells/mm2 (Fig. 2.F, H). Area occupied by α-SMA-ir myofibroblasts area 
was increased approximately 40-fold to about 130,000μm2/mm2 (Fig. 2J, L).  
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T-cells also increased from negligible numbers in controls to about 39 
cells/mm2 (Fig. 2N, P).  
 
Effect of clodronate liposomes on innervation and inflammatory cell 
composition following CAL 
In rats receiving CAL followed by intravenous injections of clodronate 
liposomes, DBH-ir sympathetic innervation density was reduced by 66% 
relative to untreated CAL ventricles, and was comparable to that of unligated 
ventricles (Fig. 2C, D).  To confirm that this reduction was not simply due to 
DBH depletion within structurally intact sympathetic axons, we 
immunostained adjacent sections for the intermediate filament protein 
peripherin, which labels all intact unmyelinated axons, and TH as an 
alternative noradrenergic marker. Staining patterns for DBH-ir axons in saline-
injected rats with coronary artery ligation were comparable to those of TH and 
peripherin (Fig. 3A, B, C).  Similarly, the reduction in numbers of DBH-ir fibers 
in rats with coronary artery ligation and clodronate liposome treatment was 
comparable to that observed for TH and peripherin (Fig. 3D, E, F).  
Clodronate liposome treatment also reduced numbers of macrophages by 
69% (Fig. 2G, H) and macrophage size by 21% (41.5 ± 2.2 μm2 with saline 
treatment and 32.7 ± 2.3 μm2 with clodronate treatment, p=0.015) , although 
they remained significantly more abundant than in control ventricles. 
Consistent with previous findings, macrophage depletion was associated with 
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reduced IFN-γ gene expression (Fig. 4A) in the infarct (Salkowski, et al., 
1995, Torres, et al., 1999), while TNF-α and MCP-1 were unchanged 
(McClellan, et al., 2003, Summan, et al., 2006) (Fig. 4B and C).  
The wound area occupied by myofibroblasts was also significantly 
reduced by 22% relative to untreated CAL tissue but remained elevated 
relative to unligated ventricles (Fig. 2K, L). T-cell numbers were not affected 
by clodronate liposome treatment (Fig. 2O, P).  
 
Effect of clodronate liposomes on infarct NGF expression  
Previous studies have implicated NGF in post-infarct sympathetic 
sprouting (Zhou, et al., 2004, Chen, et al., 2007) and we have shown in 
culture that NGF neutralization eliminates sprouting induced by the infarcted 
myocardium (Hasan, et al., 2006). Accordingly, we assessed the extent to 
which clodronate liposome treatment altered infarct NGF.  
In the infarct border region of saline treated rats, mature NGF protein was 
3.34*10-3 INT*mm2. After treatment with clodronate liposomes, NGF was 
reduced by 67% to 1.10* 10-3 INT*mm2 (Figure 5).  
To determine the contribution of the predominant NGF-expressing  cell types 
in the vicinity of the infarct (Hasan, et al., 2000, Moalem, et al., 2000, Caroleo, 
et al., 2001, Hasan, et al., 2006), we analyzed the NGF expression of 
macrophages, myofibroblasts and T-cells.  In ventricles with sham ligations, 
no macrophages were observed below the untied ligature and therefore did 
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not contribute to NGF expression in the control ventricle (Fig. 6A, B, C).  
Following CAL, all CD68-ir macrophages expressed NGF-ir (Fig. 6D, E, F, G). 
After clodronate liposome treatment, CD68-ir macrophages that remained 
continued to express NGF-ir at intensities comparable to untreated CAL (Fig. 
6D, I, J, K). To assess how macrophage depletion affected NGF tissue 
content, we computed section area occupied by NGF-ir macrophages. While 
macrophages did not contribute to NGF-ir in control tissues, section area 
occupied by NGF-ir macrophages was ~50,000 μm2/mm2 in the saline CAL 
group, and this was reduced to ~13,000 μm2/mm2 by clodronate liposome 
treatment (Fig. 6H).  
In ventricles of rats with sham ligations, NGF-ir was observed in only 17 ± 
3 % of myofibroblast α-SMA-ir cytoplasmic area (Fig. 7A, B, C, D) and this 
was unchanged by clodronate liposome injections (Fig. 7D). Section area 
occupied by NGF-ir and αSMA-ir colocalization was about 1,300 μm2/mm2. 
Because of the limited numbers of myofibroblasts, the contribution of 
myofibroblasts to NGF expression in sham-ligated ventricles was negligible 
(Fig. 7H). Following CAL, the percentage of α-SMA-ir cytoplasm occupied by 
NGF-ir increased to 37 ± 2 % (Fig. 7D ,E , F, G), and total NGF-ir+αSMA-ir 
area increased 97-fold (Fig. 7H). Clodronate liposome-treatment did not alter 
the percentage of α-SMA-ir cytoplasm with NGF-ir (Fig. 7D, I, J, K), but the 
total area occupied by these colocalized markers decreased in concert with 
the reduction in myofibroblast content (Fig. 7 H).  
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In ventricles with sham ligations, 8 ± 8 % of TCR α/β-ir T-cells showed 
NGF-ir (Fig. 8A, B, C, D), and these occupied 32 ± 19 μm2/mm2  (Fig. 8H). In 
ventricles of sham-ligated rats receiving clodronate liposomes, the 
percentage of T-cells with NGF-ir was greater than in saline-injected controls 
(Fig. 8D) and area occupied was 517 ± 207 μm2/mm2 (Fig. 8H). CAL 
increased the percentage of T-cells expressing NGF and their area relative to 
saline injected sham controls (Fig. 8D, E, F, G, H). In addition, in CAL rats 
receiving clodronate liposomes, the number of TCR α/β-ir T-cells expressing 
NGF-ir was increased, as was the area occupied by NGF-ir within these cells 




Prolonged myocardial ischemia leads to extensive cardiomyocyte 
necrosis, which results in both a reduction in cardiac performance and a 
thinning of the myocardial wall. Accordingly, it is important that cellular debris 
be removed and that tissue repair be initiated quickly in order to maintain 
cardiovascular homeostasis. In association with this damage, locally 
produced chemokines and cytokines initiate an inflammatory response that 
attract and activate circulating macrophages. These cells perform an 
important role in removing debris left by the necrotic cells (Frangogiannis, 
2006). Additionally, they are essential for tissue repair (Fischer, et al., 2007, 
Westermann, et al., 2007, Frantz, et al., 2008, Miura, et al., 2008). Growth 
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factors released by these cells promote proliferation of endothelial cells, 
fibroblasts and myofibroblasts, which are important in revascularization, 
forming extracellular matrices, and providing tensile strength to the scar. 
Proinflammatory cytokines are present in experimental models of myocardial 
infarction (Frangogiannis, et al., 1998a, Frangogiannis, et al., 1998b, Dewald, 
et al., 2004) and are produced by many cells types (Gessani, et al., 1998, 
Deng, et al., 2000, Frucht, et al., 2001, Akasaka, et al., 2006, Spiekstra, et al., 
2007). These cytokines, activate macrophages (Green, et al., 1990) and 
promote T-cell activation and proliferation (Mizutani, et al., 1989). NGF also 
plays important roles in differentiation and proliferation of inflammatory cells 
(Mizutani, et al., 1989, Barouch, et al., 2001, Micera, et al., 2003). In addition 
to its role in inflammatory cell differentiation, NGF is known to promote 
aggressive sprouting of sympathetic nerves. By activating the trkA receptor 
present on sympathetic axons, NGF promotes regeneration and outgrowth. 
Hence, NGF is important in both the inflammatory response and in the 
remodeling of innervation following infarction.  
Previous studies have shown that, within the cardiac ischemic wound, 
multiple cell types can synthesize NGF. Both NGF mRNA and protein have 
been detected in post-infarction macrophages and myofibroblasts, in T-cells 
and in surviving cardiac ventricular myocytes as well as vascular smooth 
muscle (Zhou, et al., 2004, Hasan, et al., 2006, El-Helou, et al., 2007). 
Therefore, multiple cell types may contribute to local NGF production. The 
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extent to which these various cell types contribute to sympathetic axon 
remodeling after infarction is not clear. In the present study, we focused on 
the role of macrophages. Macrophages have been implicated in neuronal 
sprouting after wounds in the central nervous system (Batchelor, et al., 2002). 
In addition to synthesizing NGF, macrophages release a variety of other 
factors that may be important in orchestrating recruitment, proliferation and 
differentiation of other wound cell types.  
To selectively deplete macrophages, we used liposomes containing 
clodronate (Van Rooijen, et al., 1994). Clodronate liposomes do not cross 
blood vessel walls but are phagocytosed by circulating monocytes where the 
accumulated clodronate leads to irreversible toxicity and apoptosis (van 
Rooijen, et al., 1996). Sustained treatment is reported to effectively reduce 
tissue macrophage populations (Popovich, et al., 1999, Galeazzi, et al., 
2000), and our regimen reduced CD68-ir macrophages by 69% in infarcted 
hearts, comparable to that reported previously (van Amerongen, et al., 2007). 
In addition, we observed that the size of surviving macrophages was 
modestly reduced. Consistent with this reduction,  mRNA encoding IFN-γ, 
which is expressed mainly by macrophages, T-cells and NK cells (Gessani, et 
al., 1998, Munder, et al., 1998, Frucht, et al., 2001) was reduced by 31%, and 
this reduction is consistent with findings by others (Salkowski, et al., 1995, 
Torres, et al., 1999).  However, some other cytokines did not show significant 
changes. Neither TNF-α, a cytokine secreted by multiple cell types including 
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macrophages, neutrophils, mast cells and cardiomyocytes (Frangogiannis, et 
al., 1998a, Irwin, et al., 1999) nor MCP-1, which is is expressed by 
macrophages, endothelial cells, fibroblasts, neutrophils and cardiomyocytes 
(Onai, et al., 2004), were significantly decreased by clodronate liposomes.  
While it is unclear how cytokine content is maintained in the face of 
macrophage depletion, our findings are consistent with others where these 
proteins were found to be unchanged (McClellan, et al., 2003, Summan, et 
al., 2006). These observations suggest that the ability of clodronate 
liposomes to prevent sympathetic hyperinnervation is probably not due to a 
generalized suppression of inflammatory proteins within the infarcted tissue. 
While clodronate liposome treatment depleted wound macrophages, 
effects on other cells were limited. Clodronate liposome treatment did not 
affect T-cell numbers, although it did cause a modest reduction in wound area 
occupied by αSMA-ir myofibroblasts. This effect appears to be confined to the 
wound myofibroblasts, as treatment did not alter the small numbers of 
myofibroblasts present in non-infarcted hearts. Clodronate liposomes are 
known to be highly selective for phagocytic macrophages (Van Rooijen, et al., 
1994), so it seems unlikely that this is a direct effect on myofibroblasts, which 
are not known to be phagocytic.  Rather, it is likely to have occurred 
secondary to the depletion in macrophages. Myofibroblasts transdifferentiate 
from several cell types including fibroblasts and pericytes (Schmitt-Graff, et 
al., 1994, Gabbiani, 1996, Hasan, et al., 2000). Development of the 
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myofibroblast phenotype requires the presence of various secreted proteins 
including TGF-β (Desmouliere, et al., 1993, Dubinett, et al., 1993) which can 
be released by macrophages (Assoian, et al., 1987). In addition, 
macrophages can express αSMA (Hasan, et al., 2000) and may themselves 
be precursors to myofibroblasts. Depletion of macrophages by clodronate 
liposomes may thus account for some of the reduction of αSMA-ir 
myofibroblasts as well. Accordingly, clodronate-induced depletion appears to 
have a small but significant effect in reducing myofibroblast contributions to 
the ischemic wound as a result of an altered wound milieu, reduced precursor 
cell numbers, or both. 
Clodronate treatment produced a marked reduction in the numbers of 
sympathetic nerves in the vicinity of the infarct.  Sympathetic hyperinnervation 
is well documented in the infarct border zone (Vracko, et al., 1991, Hasan, et 
al., 2006) . While sympathetic nerves may play a role in tissue remodeling 
after injury (Kim, et al., 1998, Smith, et al., 2002, Souza, et al., 2005), a link 
between sympathetic hyperinnervation and post-infarct arrhythmias is 
believed to underlie sudden cardiac death (Cao, et al., 2000b).  While the 
present study provides strong evidence that sympathetic hyperinnervation 
requires increased numbers of macrophages, additional studies with larger 
numbers of rats and a more protracted time course will required to assess 
any impact of clodronate lipsome treatment on post-infarct survival. Similarly, 
the extent to which other factors reported to modulate infarct sympathetic 
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hyperinnervation, which include estrogen (Lee, et al., 2007b), statin treatment 
(Lee, et al., 2007a), and glucocorticoids (El-Helou, et al., 2007), affect 
macrophage dynamics and NGF expression remain to be elucidated.  
The present findings show that, in the absence of normal numbers of 
macrophages, sympathetic hyperinnervation fails to develop at the site of the 
ischemic injury. This is not likely to be due to an effect of clodronate 
liposomes on sympathetic innervation as sympathetic nerve density was 
unaffected in sham-ligation subjects.  Because clodronate liposomes directly 
affect macrophage numbers, this represents a probable cause for the 
reduced numbers of sympathetic nerves. Moreover, macrophages are robust 
sources of NGF, and this neurotrophin is required for post-infarct sympathetic 
sprouting (Hasan, et al., 2006).  However, macrophages secrete other factors 
that may modulate phenotype of other cell types within the wound, including 
their NGF expression. For example, treatments with clodronate liposomes 
were found to reduce cytokines produced by macrophages such as IFN-γ 
(Salkowski, et al., 1995, Torres, et al., 1999), which may indirectly reduce 
sympathetic outgrowth by modulating NGF but is not known to directly elicit 
sympathetic sprouting. Accordingly, we assessed changes in NGF 
expression. 
Clodronate liposome treatment decreased the expression of NGF by 67% 
in the border region compared to saline liposome treatment suggesting that 
the decrease of this neurotrophin could account for the suppression of 
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sympathetic hyperinnervation following clodronate liposome treatment. To 
determine the contribution of the different inflammatory cell types to this 
decrease, we analyzed the cellular distribution of NGF. 
In sham operated hearts, NGF-ir was present at low levels in 
cardiomyocytes and in a few CD68-ir myofibroblasts and TCR α/β-ir T-cells. 
Following infarction, there was a marked increase in NGF-ir in the infarct 
border region, and most was colocalized with CD68-ir macrophages and 
αSMA-ir myofibroblasts; TCR α/β-ir T-cells showed intense NGF 
immunofluorescence but were relatively few in number so that their 
contribution to overall NGF expression was quite small (~1% of the tissue 
area showing NGF-ir).   
Clodronate liposome treatment elicited a marked reduction in overall NGF 
immunostaining in the infarcted tissue. Coincident with the reductions in 
macrophage numbers (and to a lesser extent size), the total area occupied by 
colocalized CD68 and NGF immunofluorescence was reduced some 76% 
relative to saline treatment. Due to the reduction of αSMA-ir myofibroblast 
area, NGF expression by this cell population was also reduced after 
clodronate liposome treatment. Although αSMA-ir myofibroblast area showed 
a modest reduction after clodronate liposome treatment, the reduction in NGF 
content appeared to be more marked, suggesting that the reduction in 
macrophages may have also suppressed NGF expression in the 
myofibroblasts. Interestingly, while NGF immunoreactivity presented by both 
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macrophages and myofibroblasts was reduced, expression by T-cells was 
increased, now accounting for about 10% of NGF-ir cellular area. Overall 
however, macrophage depletion by clodronate liposomes substantially 
reduced NGF in the region of the wound.  
While some regions of the post-infarct heart show hyperinnervation, other 
ventricular regions have a pronounced loss of sympathetic nerves (Li, et al., 
2004), suggesting that the wound environment contains both attractive and 
repulsive factors for sympathetic axons which could account for the 
inhomogeneity of sympathetic innervation throughout the infarct. It is known 
that cardiac tissue expresses Sema3A, which acts to suppress cardiac 
innervation (Ieda, et al., 2007). It may therefore be the case that the 
abundance of NGF in the infarct region induces sympathetic sprouting by 
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Figure 1. Infarct assessment. A: Six sections taken at ~1.7 mm intervals 
through the entire ventricle stained with Masson’s trichrome. Collagen is 
lightly stained and cardiomyocytes are darker. Arrow in the schematic 
diagram shows where the left coronary artery was ligated, and dotted lines 
show the levels from which each of the representative sections was taken. 
RV: right ventricle, LV: left ventricle. LA: left atrium. Boxes show the regions 
sampled for the analysis sympathetic innervation and inflammatory cells. B: 
Higher magnification of area shown in section 3. Boxes in B show fields within 
the left lateral posterior aspect of the infarct sampled for quantification. Scale 
= 1mm. C: Approximately 2mm section through a CAL heart stained with 
TTC. Large arrow shows the suture. Thin arrow shows the infarct, which fails 






















Figure 2. Innervation and inflammatory cell composition of uninjured and 
injured hearts. Immunostaining of ventricular tissue sections for dopamine β-
hydroxylase (DBH) as a sympathetic nerve marker (A,B,C), CD68 as a 
macrophage marker (E,F,G), α-Smooth muscle actin (αSMA) as a 
myofibroblast marker, and TCRα/β as a T cell marker (M,N,O).  Sections were 
obtained from rats receiving sham ligation and saline injections (S+S; 
A,E,I,M), coronary artery ligation and saline injections (C+S; B,F,J,N), or 
coronary artery ligations plus clodronate liposomes (C+C;C,G,K,O).  Scale 
bar = 10 μm in C and 50µm in G, K, and O.  D. Quantitative analysis of 
sympathetic innervation density as determined by the percentage of section 
sample area occupied by DBH-ir nerves. H.  Quantitative analysis of tissue 
macrophages expressed as the number of CD68-ir cells per mm2.   L.  
Quantitative analysis of tissue myofibroblasts as determined by the section 
sample area occupied by α-SMA-ir.  P.  Quantitation of tissue T-cells as 

























Figure 3. Changes in sympathetic innervation after clodronate liposome 
treatment are reflected by multiple markers.  Adjacent sections from hearts 
receiving coronary artery ligation plus saline (C+S) or ligation plus clordronate 
liposomes (C+C) were immunostained for DBH which characterizes 
noradrenergic neurons (A,D), the intermediate filament protein peripheral 
which stains intact unmyelinated axons (B, E), and tyrosine hydroxylase 
which is a marker for catecholaminergic axons (C, F).  Levels of innervation 
density were comparable under different treatments with all markers. Scale 



























Figure 4. Effect of clodronate liposomes on IFN-γ, TNF-α and MCP-1 mRNA 
in the infarction border region.  Infarct tissue was assessed by RT-PCR for 
Interferon-γ (IFN),  tumor necrosis factor (TNF-α) and macrophage 
chemotactic protein-1 in infarct tissue 7 days after CAL in rats receiving 
saline-containing liposomes (C+S) or clodronate-containing liposomes (C+C). 
RT-PCR product was analyzed densitometrically (Intensity/mm2) and 
































Figure 5. Effect of clodronate liposomes on NGF in the infarction border 
region. Tissue was assessed by western blot for NGF 7 days after CAL in rats 
receiving saline-containing liposomes (C+S) or clodronate-containing 
liposomes (C+C).  Product was analyzed densitometrically and normalized to 
































Figure 6. Effect of clodronate liposomes on macrophage NGF expression.  
Immunostaining for CD68 as a macrophage marker (A, E,I), and costained for 
NGF (B,F,J), merged images (C,G,K). Sections were obtained from rats 
receiving sham ligation and saline injections (S+S,A,B,C), coronary artery 
ligation and saline injection (C+S,E,F,G), or coronary artery ligation plus 
clodronate liposomes (C+C,I,J,K). Scale bar = 10 µm. Quantitative analysis of 
the percentage (D) and the area (H) of macrophages expressing NGF-ir as 






























Figure 7. Effect of clodronate liposomes on NGF expression by 
myofibroblasts. Immunostaining for α-SMA as a myofibroblast marker (A,E,I), 
and costained for NGF (B,F,J), and merged images (C,G,K). Sections were 
obtained from rats receiving sham ligation and saline injections (S+S,A,B,C), 
coronary artery ligation and saline injection (C+S,E,F,G), or coronary artery 
ligation plus clodronate liposomes (C+C,I,J,K). Scale bar = 50 µm. 
Quantitative analysis of the percentage (D) and the area (H) of myofibroblasts 
expressing NGF-ir as determined by the area of α-SMA-ir coexpressing NGF-






























Figure 8. Effect of clodronate liposomes on NGF expression by T-cells. 
Immunostaining for TCR α/β as a T-cell marker (A,E,I), and costained for 
NGF (B,F,J), merged images (C,G,K). Sections were obtained from rats 
receiving sham ligation and saline injections (S+S,A,B,C), coronary artery 
ligation and saline injection (C+S,E,F,G), or coronary artery ligation plus 
clodronate liposomes (C+C,I,J,K). Arrows shows blood vessels expressing 
NGF. Scale bar = 50 µm. Quantitative analysis of the percentage (D) and the 
area (H) of T-cells expressing NGF-ir as determined by the area of TCR α/β-ir 



































CHAPTER 4. CHRONIC β1 ADRENOCEPTOR BLOCKADE INCREASES 

















Rationale: β-adrenoceptor antagonists are useful in treating cardiovascular 
disorders, but discontinuation is associated with sympathetic hyperactivity 
that can lead to severe complications.  
 
Objective: We evaluated whether β-blockers alters sympathetic axon 
outgrowth, ventricular sympathetic innervation density, and ventricular 
function.  
 
Methods and Results: Sprague-Dawley rats with or without coronary artery 
ligation received adrenergic receptor blockers or saline infusions for a week. 
Infarct sympathetic hyperinnervation was unaffected by the non-selective β-
blocker propranolol, but this treatment increased innervation of myocardium 
with intact perfusion in ligated and control rats. The β1 adrenoceptor 
antagonist metoprolol also increased sympathetic axon density but the α-
blocker phentolamine did not.  Two days following propranolol withdrawal, left 
ventricular responsivity to direct β receptor activation was similar to untreated 
rats, but end systolic pressure and Max dP/dt in response to norepinephrine 
mobilization by tyramine were greater, consistent with enhanced sympathetic 
neuroeffector transmission.  To assess mechanisms of hyperinnervation, we 
cultured neonatal sympathetic neurons with propranolol or metoprolol; both 
increased axonal outgrowth. RT-PCR revealed β1-adrenoceptor mRNA in 
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sympathetic cultures, implying that β-blockers could act directly on neuronal 
receptors. To determine if sprouting is due to β-blockade of growth-inhibiting 
signals by intrinsically synthesized norepinephrine, we prevented synthesis 
with α-methyl p-tyrosine. This enhanced outgrowth, while concurrent 
dobutamine administration reduced sprouting, confirming norepinephrine-
mediated inhibition of outgrowth via β1 adrenoceptors. 
 
Conclusions: Sympathetic axon outgrowth, and therefore target innervation 
density, is negatively regulated by β1 autoreceptors.  Sympathetic 
hyperinnervation occurring as a result of chronic β-adrenoceptor blockade is 




β-adrenergic receptor (βAR) antagonists are used to manage a variety 
of disorders including hypertension, angina, arrhythmias, myocardial 
infarction and heart failure (Yusuf, et al., 1985, Viskin, et al., 1995). These 
agents block norepinephrine (NE) and epinephrine interactions with β-
adrenergic G protein-coupled receptors, thus preventing Gs protein activation, 
formation of the second messenger cAMP, and activation of protein kinase A 
(Lefkowitz, 2004).  Beta-blockers decrease cardiac inotropy, chronotropy and 
dromotropy, thus reducing blood pressure, conduction system excitability, and 
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myocardial oxygen demand.  Most ventricular AR effects are attributed to β1 
receptors on cardiomyocytes, which induce calcium influx via the L-type 
calcium channels and enhance contractile force (Wang, et al., 2004).  
Although β-blockers are widely used clinically, discontinuation is 
associated with serious adverse effects including chest pain, tachycardia and 
other arrhythmias, palpitations, and occasionally myocardial infarction (Nattel, 
et al., 1979).  Moreover, withdrawal can contribute to increased mortality; β-
blocker discontinuation following vascular surgery increases mortality 6-fold 
relative to patients remaining on β-blockers, and 3-fold relative to those not 
receiving drugs (Hoeks, et al., 2007).  
Adverse effects typically are attributed to exaggerated sympatho-
adrenal responsiveness, generally ascribed to increased β-receptor density 
and sensitivity resulting from long-term receptor blockade (Heilbrunn, et al., 
1989). While receptor supersensitivity can certainly contribute to increased 
sympatho-adrenal tone, it is not clear whether other factors also participate in 
hyper-responsiveness after βAR blockade.  For example, propranolol 
treatment increases plasma catecholamine levels (Rahn, et al., 1978), which 
may reflect reflex compensation but could also suggest changes in 
sympathetic neuroeffector gain.  There is precedence for suggesting that 
transmitter blockade can influence neuronal architecture; in developing 
central monoaminergic neurons, serotonin administration reduces outgrowth, 
presumably as a result of autoreceptor activation (Haydon, et al., 1984, 
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Whitaker-Azmitia, et al., 1986).  If comparable processes occur in adult 
sympathetic neurons, then cardiac innervation density may be increased by 
AR blockade.  Since sympathetic hyperinnervation is believed to underlie 
enhanced end organ responsiveness in animal models (Kondo, et al., 1996),  
increased cardiac innervation may therefore contribute to cardiac dysfunction 
after β-blocker withdrawal.  In the present study, we examined effects of βAR 
blockade on cardiac sympathetic innervation of adult rats and neurite 
outgrowth in sympathetic neuronal cultures.  
 
MATERIAL AND METHODS 
In vivo experimental preparations 
All experimental protocols conformed to NIH guidelines and were approved 
by the University of Kansas Medical Center Animal Care and Use Committee.  
Sprague Dawley rats aged 60 days received coronary artery ligation (CAL) 
(Wernli, et al., 2009) or were unoperated.  Concurrently, minipumps were 
implanted containing saline or propranolol (release rate of 13.2 mg/kg/day) to 
produce β receptor blockade (Conlon, et al., 1991) or  phentolamine (release 
rate of 1 mg/kg/day) to produce α blockade (Steinle, et al., 2002). Unoperated 
rats also received metoprolol (36 mg/kg/day) which blocks β1 but not β2 
receptors (Ablad, et al., 1975, DiBona, et al., 1999). Effectiveness of blockade 
was confirmed in subsets of rats at 7 days following minipump implantation.  
Phentolamine prevented the normal increase in pupil diameter following 
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topical application of 1% NE in saline to the eye. Propranolol and metoprolol 
blocked tachycardic responses to iv administration of isoproterenol by 79 and 
45%, respectively.  Metopropolol’s selectivity for β1AR was confirmed by 
showing that the β2AR-mediated increase in gracilis muscle blood flow in 
response to isoproterenol was not affected.   
 
Cardiac sympathetic neuroeffector function after β-blocker 
discontinuation 
Cardiac ventricular neuroeffector function was assessed 2 days 
following discontinuation of chronic β-AR blockade in 4 saline-infused and 4 
propranolol-treated rats.  A calibrated catheter (SPR 838, Millar Instruments) 
for measuring pressure-volume loops was introduced in the left ventricle via 
the right carotid artery (Pacher, et al., 2008).  After administering the 
ganglionic blocker chlorisondamine, tyramine was administered iv in graded 
doses until maximum left ventricular (LV) functions were achieved. After 
parameters returned to baseline, graded doses of isoproterenol were 
administered in until maximum values were acheived.  Heart rate, end systolic 
pressure, end diastolic pressure, and maximal and minimal first derivative of 
pressure (Max dP/dt and Min dP/dt) were measured.  Isoproterenol ED50 for 





Analysis of cardiac sympathetic innervation density and infarct volume 
Following adrenergic receptor blockade for 7 days, hearts were 
excised, snap-frozen and cryosectioned at 10 μm thickness.  Six stepped 
serial sections separated by ~2mm were fixed in 4ºC methanol and 
immunostained for dopamine-β -hydroxylase (DBH) as a marker for 
noradrenergic sympathetic axons. In sections from non-ligated hearts, 6 fields 
evenly distributed in the left lateral posterior area of the heart were captured.  
In CAL hearts, images of 6 fields evenly distributed in the left lateral posterior 
area (infarct border region) and images of 6 fields evenly distributed in the 
non-ischemic posterior area of the heart were taken (Figure 1A) (Wernli, et 
al., 2009). Nerve density was calculated as reported previously (Wernli, et al., 
2009). Infarct volume was calculated by measuring infarct area stained with 
Masson’s Trichrome (Wernli, et al., 2009) in each section and multiplying this 
by the distance between sections.  
 
Cardiomyocyte culture and protein synthesis  
 To investigate whether ARs modulate cardiac nerve growth factor 
(NGF) synthesis, hearts were harvested from pups (postnatal day 0-2), 
disassociated, and cardiomyocytes plated in DMEM/F12. After 3 days, culture 
medium was replaced with medium containing the non-selective α-agonist 
phenylephrine (0.1-10 μmol/L) or the non-selective β-agonist isoproterenol 
(0.1-10 μmol/L). Media was collected after 24 hours, proteins precipitated and 
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resolved using SDS-PAGE, transferred to polyvinylidene difluoride 
membranes and probed in triplicate with an antibody to NGF. Cultured 
cardiomyocytes were fixed in buffered formalin and stained for actin 
cytoskeleton (Alexa Fluor594-Phalloidin), NGF or the pro-protein convertase, 
furin.  
 
Sympathetic Neuronal Cultures 
To assess effects of β-AR blockade on sympathetic axon outgrowth, 
cultures were conducted on superior cervical ganglia (SCG) neurons obtained 
from newborn rats. Neurons were dissociated, suspended in neurobasal 
medium, and plated (~4x104 per well) on glass coverslips in control medium 
or medium containing propranolol (10-10 mol/L to 10-8 mol/L) or metoprolol (10-
10 mol/L to 10-6 mol/L). Other cultures were conducted with 10-8 mol/L 
dobutamine, with or without 5 μmol/L α-methyl-p-tyrosine (AMPT).  
Treatments were conducted in triplicate, and each experiment repeated at 
least twice. 
 After 48h, cultures were fixed in formalin and immunostained for 
peripherin to reveal all axons and soma. Neurite outgrowth was measured in 
six images distributed equally within each well and expressed as area per 





RT-PCR for β1 receptor mRNA 
β1AR gene expression was assessed in SCG cultures by RT-PCR. Heart 
tissue or SCG neurons cultured for 48h were homogenized in ice cold trizol 
and total RNA (1μg) was reverse transcribed.  β1-AR cDNA was amplified 
using specific  primers and PCR product analyzed by electrophoresis. 
 
Statistical Analyses 
Data were analyzed using student’s T-test or one way ANOVA for 
multiple comparisons followed by Newman-Keuls test. Data are expressed as 
mean ± SEM. Statistical significance was accepted at P<0.05.   
 
RESULTS 
Effect of AR blockade on sympathetic innervation following CAL 
 Clinically, β-blockers are administered following myocardial infarction 
to reduce mortality in the post-infarct period. Because the infarct border 
region is characterized by sympathetic axon proliferation that is linked to 
ventricular fibrillation and sudden cardiac death (Cao, et al., 2000b), we 
examined whether AR blockade alters infarct sympathetic hyperinnervation in 
rats following CAL.  To exclude the possibility that AR blockade influences 
innervation indirectly by affecting infarct size, we measured infarct volumes.  
These were comparable in all groups (saline = 118 ± 5 mm3; propranolol = 
124 ± 13 mm3; phentolamine = 129 ± 7 mm3).  
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Infarcted myocardia showed increased innervation density similar to 
that reported previously using analogous experimental approaches (Hasan, et 
al., 2006, Wernli, et al., 2009).  Quantitative analysis of border region 
sympathetic innervation in saline-infused rats confirmed that innervation 
density was substantially increased relative to non-ischemic myocardium 
remote to the infarct (Figure 1).  Relative to the saline-infused CAL rats, 
neither propranolol nor phentolamine altered innervation density within the 
infarct border region.  
Examination of innervation in the posterior ventricular region remote to 
the infarct in CAL rats showed that propranolol affected sympathetic axon 
distribution in non-ischemic myocardium. Relative to saline-infused rats, 
sympathetic axon density in the remote region was increased by 41% 
(P<0.05), whereas innervation density in hearts receiving the αAR blocker 
phentolamine was similar to that to those receiving saline (Figure 1B). 
 
Effect of AR blockade on sympathetic innervation density in uninjured 
hearts 
 To determine if βAR antagonism alters ventricular innervation density 
in hearts not subject to ischemic damage, we infused control rats with saline, 
propranolol, metoprolol or phentolamine for 7 days.  In control rats receiving 
saline, quantitative analysis of DBH-immunoreactive (-ir) sympathetic axons 
showed that innervation occurred at a density similar to that reported 
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previously (Wernli, et al., 2009) (Figure 2A). DBH-ir fibers appeared more 
abundant in rats receiving propranolol for 7 days (Figure 2B) and quantitative 
analysis revealed a 48% increase in ventricular sympathetic axon density 
(Figure 2E).   
 Propranolol may increase innervation density by blocking β1 or β2ARs.  
To determine if selective blockade of β1ARs induces outgrowth, metoprolol 
was given for 7 days by minipump.  DBH-ir fiber density after metoprolol 
treatment was also increased (Figure 2C), and quantitative analysis showed a 
44% increase relative to saline controls (Figure 2E). The density of DBH-ir 
fibers after phentolamine treatment was similar to that of controls (Figure 2D), 
showing that α-blockade did not modify cardiac sympathetic innervation.  
 
Ventricular sympathetic neuroeffector function following β-blocker 
discontinuation 
 We assessed ventricular function at 48 h after propranolol 
discontinuation to determine if sympathetic hyperinnervation leads to 
increased sympathetic neuroeffector properties.  We used the βAR agonist 
isoproterenol to assess whether chronic propranolol infusion for 7 days had a 
direct effect on cardiac function.  Determination of the isoproterenol ED50 for 
heart rate and Max dP/dt showed that these were comparable in saline- and 
propranolol infused rats (0.06±0.03 vs. 0.05 ± 0.02 mg/kg for heart rate, and 
0.05±0.01 and 0.06 ± 0.01 mg/kg for MaxdP/dt, in saline or propranolol-
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treated rats, respectively), confirming prior reports in humans and rats that 
βAR sensitivity is normal at this time (Nattel, et al., 1979, Hedberg, et al., 
1980). 
 Left ventricular function in response to a maximally effective dose of 
isoproterenol was comparable in both saline- and propranolol-infused rats 2 
days after discontinuation, indicating that chronic propranolol did not affect 
ventricular performance under these conditions.  Maximal displacement of NE 
stores by tyramine increased cardiac function to a greater extent in 
propranolol treated rats.  Relative to saline-infused controls, propranolol 
treated rats had 57% greater end systolic pressure, Max dP/dt was increased 
by 56%, and Min dP/dt by 92% (Table 1).  
 
AR and cardiomyocyte NGF synthesis 
 To determine if β-blockers increase sympathetic cardiac innervation by 
modulating NGF synthesis, we cultured cardiomyocytes in the presence or 
absence of AR agonists and measured NGF protein produced and secreted 
in vitro. Cardiomyocytes in culture showed spontaneous contractions and 
mature cytoskeletal features, as visualized with phalloidin (Figure 3A).  These 
cells were immunoreactive for NGF protein (Figure 3B), and the 
endopeptidase furin (Figure 3C), which converts pro-NGF to mature NGF, 
thus determining neuritogenic properties of the secreted neurotrophin (Lee, et 
al., 2001).  Western blot analysis of the medium revealed a strong band at 40 
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kDa corresponding to pro-NGF, with weaker bands of lower molecular 
weights.  Addition of either the α-agonist phenylephrine or the β-agonist 
isoproterenol in concentrations from 10 -10 to 10 -8 mol/L failed to alter the 
amount or isoform profile of secreted protein (Figure 3D).  
 
AR and sympathetic neuritogenesis in vitro 
 We used neuronal cultures to assess whether βAR blockade promotes 
sympathetic neuritogenesis by acting directly on postganglionic sympathetic 
neurons.  After 48 h in culture, SCG neurons had elaborated many neurites 
(Figure 4A).  Addition of 10-10 mol/L propranolol to the culture medium 
appeared to increase neurite area (Figure 4B), whereas outgrowth appeared 
more comparable to controls in cultures with propranolol at 10-8 mol/L (Figure 
4C).  Quantitative analysis confirmed a significant increase in neurite area per 
neuron of 17 % (Figure 4D). 
 To assess whether a β1-AR antagonist is also effective in increasing 
neurite outgrowth, we cultured SCG neurons in the presence of metoprolol. At 
a concentration of 10-8 mol/L, neurite outgrowth appeared greater than in 
control cultures (Figure 5A, B), while outgrowth again appeared comparable 
to controls at the higher concentration of 10-6 mol/L (Figure 5C).  Quantitation 
confirmed that the lower concentration of metoprolol increased neurite 




Βeta-1 AR gene expression in SCG neurons 
 To confirm that sympathetic neurons express mRNA encoding the β1 
AR and are therefore potentially capable of responding to β1AR blockade, we 
performed RT-PCR analysis of SCG neurons after 48h in culture.  The 
sensitivity of our primers was confirmed using ventricular myocardium as a 
control, which showed a strong band at the predicted product size (Figure 6).  
RT-PCR of SCG neurons also yielded PCR product of the correct size, albeit 
of less intensity than that of cardiac muscle (Figure 6). 
 
Norepinephrine synthesis and sympathetic axon outgrowth 
 We investigated the mechanism by which β-AR antagonists act on 
sympathetic neurons to enhance axonal outgrowth. Because β-AR 
antagonists increase axonal outgrowth, we queried as to whether a β1AR 
agonist would inhibit outgrowth.  We cultured SCG neurons alone (Figure 7A) 
or in the presence of the selective β1-agonist dobutamine (Figure 7B).  
Quantitative analysis showed that dobutamine was ineffective in decreasing 
axonal outgrowth over a wide range of concentrations (Figure 7E, a 
representative concentration of 10 -8 mol/L is shown here).   
 Because SCG neurons in culture express proteins for catecholamine 
biosynthethesis and storage, NE is likely to be synthesized and released in 
these preparations, raising the possibility that β1-AR activation is ongoing and 
may be already maximal.  To determine if NE synthesized in culture tonically 
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inhibits axonal outgrowth, we blocked NE synthesis with AMPT, a competitive 
inhibitor of tyrosine hydroxylase.  Neurite outgrowth appeared to be greater in 
cultures containing AMPT (Figure 7C), and quantitation confirmed a 35% 
increase relative to controls (Figure 7E). To confirm that AMPT acted to 
increase neurite outgrowth by eliminating tonic β1AR activation, we now 
added dobutamine to these cultures.  This β1 agonist suppressed the AMPT-
mediated increase in axon outgrowth to a level comparable to that of controls 
(Figure 7D, E). 
 
DISCUSSION 
βAR antagonists and post-infarct sympathetic hyperinnervation 
Beta-blocker administration is a mainstay in managing patients with 
reduced left ventricular function after ischemic injury.  Multiple studies have 
shown that administration of β blockers that selectively block β1-ARs, or 
combine this effect with antagonism of other ARs, are important in achieving 
long-term improvement and in preventing post-myocardial infarction sudden 
death (Hunt, 2005). β blockers exhibit a number of actions that may contribute 
to improved outcome including reducing cardiac excitability and myocardial 
oxygen consumption, and reducing plasma angiotensin II levels via β1AR-
associated changes in cAMP formation and channel ion flux (Ichihara, et al., 
1995, Lipsky, et al., 2008).  In addition to these direct effects, βAR blockade is 
also associated with a number of indirect effects.  For example, reduced 
95 
 
blood pressure that can occur with β blocker administration can lead to 
reflexive increases in sympathetic tone (Floras, et al., 1988), and chronic 
receptor inactivation may result in increased receptor numbers and enhanced 
signaling mechanisms (Haeusler, 1990). 
 In keeping with its ability to reduce the risk of post-infarct sudden 
cardiac death, it has been postulated that βAR blockade might improve 
outcomes by reducing sympathetic hyperinnervation in the infarct border zone 
(Jiang, et al., 2007).  Because βARs can upregulate NGF synthesis in some 
cell types (Carswell, et al., 1992) and NGF is required for post-infarct 
sympathetic sprouting, βAR blockade might reduce cardiac excitability by 
limiting the proliferation of excitatory nerves by reducing NGF.  However, our 
findings here (and in contrast to an earlier report (Jiang, et al., 2007)) showed 
no reduction in sympathetic innervation associated with the infarct.  Benefits 
of βAR blocker therapy in preventing sudden cardiac death after myocardial 
infarction are therefore likely to derive from actions aside from suppressing 
sympathetic axon sprouting at the infarct border. 
 
βAR blockers increase ventricular sympathetic innervation density in 
non-ischemic myocardium 
Despite the lack of effect on infarct innervation, healthy myocardium 
remote to the injury showed significantly greater numbers of DBH-ir axons 
following 7 days of propranolol infusion than observed in saline or 
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phentolamine-infused rats.  Because we have previously shown using pan-
neuronal markers that changes in numbers of structurally intact ventricular 
sympathetic fibers are accurately reflected in changes in numbers of DBH-ir 
or TH-ir fibers (Hasan, et al., 2006, Wernli, et al., 2009), this is consistent with 
an increase in sympathetic axon density. 
This unexpected increase in sympathetic innervation could reflect an 
anomalous interaction between the damaged heart and propranolol.  To 
exclude this possibility, we examined the effects of propranolol on non-
infarcted hearts and found that sympathetic axon density was similarly 
increased, thus implying that this is attributable directly to the β blocker. 
Propranolol is a non-selective β antagonist and, while still widely used, 
has been largely supplanted in treatment of post-ischemia sequelae by more 
selective β1 antagonists.  To determine if these newer agents also increase 
sympathetic innervation, we used metoprolol, a selective β1 antagonist.  
Metoprolol was as effective as propranolol in increasing ventricular 
sympathetic innervation density, which suggests that blockade of β1 
receptors alone is sufficient to attain this effect. 
 
Increased ventricular sympathetic innervation has functional 
consequences 
The finding of increased ventricular innervation density following β 
blocker discontinuation could have important implications if the greater 
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numbers of axons results in increased ventricular sympathetic 
neurotransmission.  In smooth muscle, sympathetic hyperinnervation has 
been associated with hypertrophy and hyper-reactivity (Scott, et al., 1983, 
Fan, et al., 1995), and increased ventricular innervation could lead to 
comparable changes.  Assessment of ventricular function 48 h after 
discontinuation, when βARs show normal sensitivity (Nattel, et al., 1979, 
Hedberg, et al., 1980), supports the idea that sympathetic hyperinnervation 
does contribute to some aspects of enhanced ventricular function.  Thus, 
chronic propranolol infusion did not itself alter cardiac properties, as 
determined by direct βAR activation by isoproterenol. In contrast, in response 
to release of sympathetic NE stores by tyramine, both end systolic pressure 
and maximum dP/dt were increased by propranolol relative to saline-infused 
rats.  While we cannot entirely rule out contributions of alterations in afterload 
that may be occurring (particularly if arteriolar sympathetic innervation is also 
increased), maximum dP/dt values are generally considered to be largely 
independent of changes in afterload (Rhodes, et al., 1993).  These findings 
therefore support the idea that increased sympathetic innervation occurring 
with β blocker administration may contribute to heightened sympathetic 





 β blockers act directly on sympathetic neurons to promote axon 
outgrowth 
Our findings show that β blockers increase ventricular sympathetic 
innervation density, implying that they provide signals that encourage axonal 
sprouting.  NGF, the prototypical  neuritogenic protein, potently promotes 
sympathetic neuritogenesis, and βAR-mediated changes in NGF could 
account for increased innervation.  However, we were unable to modulate 
cardiomyocyte NGF synthesis by AR receptor activation, suggesting a 
minimal role of target-derived NGF in this process.  
 Consistent with an action independent of the target, we found that 
both propranolol and metoprolol, at physiological concentrations 
(Abrahamsson, et al., 1990, Takahashi, et al., 1993), promoted axon growth 
in sympathetic neuronal culture. Interestingly, a 100-fold increase in 
concentration of either agent resulted in loss of neuritogenic activity.  This 
may not be surprising, as both agents at high concentrations have membrane 
stabilizing properties (Goodman, et al., 2006), and membrane stabilization by 
drugs with local anesthetic properties inhibit axon outgrowth (Ibarretxe, et al., 
2007). It therefore appears that the increased ventricular sympathetic 
innervation density we observed in vivo can be attributed in whole or large 





β1 autoceptors inhibit sympathetic neurite outgrowth 
Because both propranolol and metoprolol promote sympathetic axon 
outgrowth, it is reasonable to speculate that this action occurs via β1ARs on 
sympathetic neurons.  Prior reports have identified β1 receptors on 
postganglionic sympathetic neurons (Butler, et al., 1990, Watson-Wright, et 
al., 1991), and our RT-PCR studies confirm the presence of β1AR mRNA in 
our neuronal cultures.  Thus modulation of the activity of these β1 receptors 
could provide a mechanism whereby neurite outgrowth is regulated. 
While no previous studies have identified autoreceptor regulation of 
sympathetic outgrowth, there are several examples of neurotransmitter 
modulation of outgrowth in other systems.  Studies on the Helisoma snail 
show that neurotransmitters such as dopamine and serotonin can suppress 
neurite outgrowth (Haydon, et al., 1984, McCobb, et al., 1988).  A role for 
autoreceptors in this process may be implied, as serotonin  inhibits outgrowth 
of serotonergic axons from rat raphe neurons (Whitaker-Azmitia, et al., 1986), 
and glutamate at high doses reduces axonal and dentritic outgrowth by 
immobilizing growth cones of glutaminergic pyramidal neurons (Mattson, et 
al., 1988).  Accordingly, precedents exist for proposing that sympathetic 
neurotransmitter autoreceptors may play a role in axon outgrowth. 
If β1AR do play a role in regulating sympathetic outgrowth and therefore 
target innervation density, then a β1 agonist should serve to inhibit outgrowth. 
Our initial attempts to demonstrate this in culture using dobutamine were 
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unsuccessful, but it is well known that sympathetic neurons synthesize NE in 
culture (Landis, 1978), raising the possibility that sufficient quantities of ligand 
are produced in culture to maximally activate β1ARs so that additional ligand 
is ineffective. 
 To test the hypothesis that locally synthesized NE tonically inhibits 
axon outgrowth in culture, we inhibited catecholamine biosynthesis with the 
tyrosine hydroxylase inhibitor AMPT.  Inhibition of NE synthesis increased 
axon outgrowth to an extent similar to that seen with βAR blockade, indicating 
that NE synthesized in culture does indeed act to inhibit outgrowth.  
Consistent with our hypothesis that β1ARs inhibit outgrowth, addition of 
dobutamine to these culture where NE synthesis is blocked resulted in 
suppressed outgrowth typical of cultures in which NE is normally synthesized. 
 
Conclusion 
Our findings provide evidence for a mechanism whereby β1 
autoreceptors regulate the growth of sympathetic axons in vitro and in vivo.  
Autoreceptor blockade removes this inhibition, enabling axons to sprout to 
greater extents and thus increasing ventricular sympathetic innervation 
density.  This increased innervation is functionally relevant, as release of NE 
stores from sympathetic terminals elicits greater ventricular contractile 
responses after blocker discontinuation.  These findings suggest that rebound 
sympathetic hyperexcitability following cessation of β blocker therapy may, in 
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addition to altered receptor sensitivity, be attributable to sympathetic 
structural plasticity leading to increased target neuroeffector input. 
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Table 1. Cardiovascular function in response to isoproterenol or tyramine. 
Cardiovascular responses obtained 48 h after discontinuation of a 7 day 
infusion of saline or propranolol in response to a maximally effective dose of 
the direct β agonist, isoproterenol, or displacement of sympathetic 

































Figure 1. Adrenergic receptor blockade increases ventricular sympathetic 
innervation in non-ischemic myocardium. A: The left coronary artery was 
ligated, creating an infracted region as shown in this Masson’s Trichrome 
stained section through the ventricles at 7 days post-ligation.  Two regions 
were selected for analysis of innervation density:  region 1 comprising the 
infarct border region, and region 2, containing spared (non-ischemic) 
myocardium. Scale bar=1mm.  B: Quantitative analyses of dopamine β-
hydroxylase-immunoreactive innervation in regions 1 and 2 expressed as 
percentage area occupied by stained axons.  The infarct border showed 
hyperinnervation unaffected by administration of saline or adrenergic blockers 
by minipump for 7 days.  Non-ischemic myocardial innervation density was 
increased by propranolol relative to saline or phentolamine infusion.  *P<0.05 






















Figure 2. β adrenergic receptor blockers increase ventricular sympathetic 
innervation in uninjured hearts. A: Sections of ventricular myocardium in 
myocardium of saline-infused rats show Dopamine β-hydroxylase 
immunoreactive axons. Innervation density appears to be increased following 
a 7 day infusion of propranolol (B) or metoprolol (C), but not phentolamine 
(C).  E:  Quantitative analysis confirms increased myocardial innervation 
density with propranolol and metoprolol. * P<0.05 for propranolol and 































Figure 3.  Adrenergic receptors do not modulate cardiomyocyte NGF 
secretion. Dissociated cardiomyocytes were cultured for 3 days prior to 
treatment with phentolamine or phenylephrine.  Cardiomyocytes in culture 
show typical actin cytoskeleton after staining with phalloidin (A).  
Cardiomyocytes express NGF protein (B) and contain the pro-neurotrophin 
convertase, furin (C).  Scale bar in B = 50μm.  D:  Following culture for 48 
hours, western blot analysis of the culture medium revealed immunoreactive 
NGF, mainly as pro-NGF with a molecular mass of about 40 kDa. Treatment 
of the cultures with 0-10 μM concentrations of the α-agonist phenylephrine 































Figure 4. Propranolol increases sympathetic neurite outgrowth.  Relative to 
superior cervical ganglion neurons cultured without treatment (A), propranolol 
at a concentration of 10-10 mol/L appeared to increase neurite outgrowth (B).  
At supraphysiological doses of propranolol  (10-8mol/L, C) this effect was not 
observed. Scale bar = 50μm. D: Quantitative analysis of peripherin-
immunoreactive neurite area confirmed a dose-dependent effect of 































Figure 5. Metoprolol increases sympathetic neurite outgrowth. As compared 
to control cultures (A), cultures treated for 48h in the presence of 10-8mol/L 
metoprolol (B) showed increased neurite outgrowth, while supra-physiological 
concentrations of 10-6mol/L (C) were associated with outgrowth similar to 
controls.  Scale bar = 50μm. D: quantitative analysis confirmed a pro-
neuritogenic effect of physiological concentrations of metoprolol. * P<0.05 
































Figure 6. Sympathetic neurons contain genes encoding β1 receptors. mRNA 
extracted from purified sympathetic neuronal cultures encode sequences 
corresponding to the β1 adrenoceptor, as revealed by RT-PCR.  Ventricular 
















                
                               
 








Figure 7. Sympathetic neurite outgrowth in culture is regulated by locally 
synthesized norepinephrine acting on β1 autoreceptors. In comparison to 
control cultures (A), dobutamine at a concentration of 10-8mol/L failed to affect 
outgrowth (B) and this was confirmed over a wide range of concentrations.  
When  norepinephrine synthesis was blocked by α-methyl para-tyrosine 
(AMPT), neurite outgrowth appeared to be enhanced (C).  Addition of 
dobutamine to cultures in which norepinephrine synthesis was blocked 
diminished outgrowth (D).  Scale bar = 50μm.  E: Quantitative analysis 
confirmed the increase in neurite area in response to AMPT (*** P<0.001, 












In vivo experimental preparations 
All experimental protocols conformed to NIH guidelines and were 
approved by the University of Kansas Medical Center Animal Care and Use 
Committee. Forty six female Sprague Dawley rats (Harlan Breeding 
Laboratories; Indianapolis, IN) were obtained at 60 days of age (~200g), and 
entered into experimental groups within a week of arrival.  Twelve rats 
receiving left ventricular infarctions were anesthetized with KAX (i.p. injection 
of 60 mg/kg ketamine HCl Keta-Ject, Phoenix Scientific, St. Joseph, MO; 0.4 
mg/kg atropine sulfate, Healthcare Corp., Deerfield, IL; 8 mg/kg xylazine 
(Xyla-Ject, Phoenix Scientific, St. Joseph, MO), respired mechanically, and 
the left anterior descending coronary artery was ligated (CAL) with a silk 
suture as described previously (Wernli, et al., 2009).   
 
Adrenergic receptor blockade 
 Directly following coronary artery ligation or in otherwise unoperated 
rats, osmotic minipumps (Durect Corporation, Cupertino, CA) were inserted 
subcutaneously between the scapulae after anesthesia with KAX. Rats were 
implanted with 2ML1 minipumps containing saline (N=12 unoperated,  4 CAL) 
or propranolol (N=8 unoperated, N=4 CAL, released at a rate of 
13.2mg/kg/day to produce β receptor blockade; Sigma Chemical Co, St. 
Louis, MO) (Conlon, et al., 1991) or  2001 minipumps containing 
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phentolamine (N=4 unoperated, N=4 CAL, released at a rate of 1mg/kg/day 
via to produce α blockade (Steinle, et al., 2002); Sigma Chemical Co, St. 
Louis, MO).  In addition, six unoperated rats were implanted with 2ML1 
minipumps and received metoprolol (released at a dose 36mg/kg/day which 
blocks β1 but not β2 receptors (Ablad, et al., 1975, DiBona, et al., 1999); 
Sigma Chemical Co, St. Louis, MO).  To ensure that changes in reproductive 
hormones during the estrous cycle did not influence sympathetic innervation, 
4 unoperated saline control rats were anesthetized as above and 
ovariectomized through bilateral incisions (Zoubina, et al., 2003) a week prior 
to minipump insertion. No differences in cardiac innervation between intact 
and ovariectomized controls were observed and data from all saline controls 
were subsequently pooled.  
 
Confirmation of AR-blockade  
The effectiveness of adrenergic receptor blockade was assessed 7 
days following minipump implantations in rats anesthetized with urethane (1.5 
g/kg and given additional doses as needed, Sigma Chemical Co, St. Louis, 
MO). Because the pupillary dilator muscle mediates its action by α1 receptor, 
we confirmed α-AR blockade by topically applying a drop of 1% NE in saline 
to the eye and by measuring the pupil diameter.  
To confirm β-AR blockade, a femoral vein was cannulated, heart rate 
was recorded with a lead II electrocardiogram and a single dose of 0.2 μg/kg 
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isoproterenol was given.  We also confirmed that the dose of metoprolol  was 
selective for β1 receptors (Ablad, et al., 1975, DiBona, et al., 1999) by 
recording β2-AR-mediated blood flow from the gracilis muscle using an 
OxyFlow laser Doppler flowmetry system (Oxford Optronix Ltd, Oxford, UK).  
 
Cardiac sympathetic neuroeffector function after β-blocker 
discontinuation 
The effect of chronic β-AR blockade on cardiac ventricular 
neuroeffector function was assessed 2 days following discontinuation of drug 
administration.  Seven days after onset of propranolol or saline infusion, 
pumps were removed and, 2 days later, rats were anesthetized with urethane, 
the jugular vein was cannulated, and the ganglionic blocker chlorisondamine 
(Ecolid, Ciba Pharmaceuticals, Summit, New Jersey, 2.5 mg/kg) was 
administered intravenously. Body temperature was maintained at 37ºC with a 
heating lamp. A calibrated catheter for measuring ventricular function (SPR 
838, Millar Instruments, Huston, TX) was introduced in the left ventricle via 
the right carotid artery (Pacher, et al., 2008). After heart rate had stabilized 
(~15 minutes later), tyramine (Sigma Chemical Co, St. Louis, MO) was 
administered iv in graded doses ranging from 2 to 30 µg/kg until maximum left 
ventricular (LV) functions were achieved (65µg/kg tyramine). After heart rate 
returned to baseline (~10 min), isoproterenol (Sigma Chemical Co, St. Louis, 
MO) was administered in graded doses ranging from 0.01 to 0.15 µg/kg until 
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maximum left ventricular functions were attained (0.33 µg/kg). To assess LV 
blood volume, a cuvette calibration was performed with warm heparinized 
blood at the end of the experiments (Pacher, et al., 2008). LV functions were 
calculated using LabChart software (AD Instruments, Colorado Springs, CO) 
and exporting 5 sec selections after the last dose of tyramine and 
isoproterenol to PVAN Software (Millar Instruments, Huston, TX). Parameters 
measured were heart rate, end systolic pressure, end diastolic pressure, 
maximal and minimal first derivative of pressure (Max dP/dt and Min dP/dt) 
and arteriolar elastance. In addition, the isoproterenol ED50 of heart rate and 
Max dP/dt were calculated as indexes of β receptor sensitivity.  
 
Analysis of cardiac sympathetic innervation density and infarct volume 
Following adrenergic receptor blockade for 7 days, hearts were 
excised through a ventral midline incision, snap-frozen in Tissue Freezing 
Medium (Electron Microscopy Sciences, Hatfield, PA), and stored at -80ºC. 
Sections were cut at 10μm thickness perpendicular to the apical-basal axis 
and thaw-mounted onto slides. Sections were fixed at 4ºC in methanol for 10 
min, blocked with normal goat serum supplemented with 1% bovine serum 
albumin and incubated overnight with antibodies against dopamine-β -
hydroxylase (DBH: 1:600, rabbit IgG, Immunostar, Hudson, WI) followed by 
application of goat anti-rabbit IgG conjugated to Alexa 555 (1:500, Invitrogen, 
Carlsbad, CA) for 2 h. This antibody was previously found to be robust and 
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provide staining consistent with other sympathetic markers (Wernli, et al., 
2009). Six stepped serial sections, each separated by ~2mm, were selected 
for analysis.  In sections from non-ligated hearts, images of 6 fields evenly 
distributed in the left lateral posterior area of the heart were taken with a 40x 
objective using a Nikon Eclipse TE300 microscope. In CAL hearts, images of 
6 fields evenly distributed in the left lateral posterior area (infarct border 
region) and images of 6 fields evenly distributed in the non-ischemic posterior 
area of the heart were taken (Wernli, et al., 2009).  Nerve density was 
calculated as reported previously (Wernli, et al., 2009) by superimposing a 
stereological grid (8μm line interval) over the captured image, counting grid 
intersections transecting nerves and dividing by the total number of 
intersections within the sampled tissue. Infarct volume was calculated from 
stepped serial sections stained with Masson’s trichrome (Wernli, et al., 2009).  
Infarct volume in CAL hearts was calculated by measuring infarct area in 
each section and multiplying it by the distance between sections.  
 
Cardiomyocyte Culture and protein synthesis  
 To investigate whether AR activation modulates cardiomyocyte nerve 
growth factor (NGF) synthesis, hearts were harvested from pups and 
disassociated (Worthington Biochemical Co., Lakewood, New Jersey). 
Cardiomyocytes were plated in DMEM/F12 (Gibco, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (Sigma Chemical Co, St Louis, 
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MO) and 0.02μg/ml cytosine arabinoside (Sigma Chemical Co, St Louis, MO) 
to reduce fibroblast outgrowth. After 3 days, the culture medium was replaced 
by medium containing the non-selective α-agonist phenylephrine (0.1-10 
μmol/L; Research Biochemicals International, Natick, MA) or the non-
selective β-agonist isoproterenol (0.1-10 μmol/L; Sigma Chemical Co, St 
Louis, MO). Triplicates of each treatment media were collected after 24 hours 
and proteins were precipitated by incubating the sample with 2% Na 
deoxycholate (1% v/v sample; Sigma Chemical Co, St Louis, MO) followed by 
incubation in trichloroacetic acid (TCA; 10% v/v sample; Sigma Chemical Co, 
St Louis, MO). After centrifugation, pellets were dried and TCA was removed 
with ice cold acetone.  Pellets were resuspended in LDS sample buffer 
containing 2.5% β-mercaptoethanol (Sigma Chemical Co, St Louis, MO). 
Proteins were separated by SDS-PAGE and transferred to polyvinylidene 
difluoride membranes. Membranes were blocked with 5% nonfat dry milk in 
TBST (10mM Tris HCl, 150mM NaCL, pH 7.4 and 0.05% Tween solution-20) 
and incubated overnight at 4ºC in 1:1000 rabbit anti-NGF (Santa Cruz 
Biotechnology, Santa Cruz, CA) in TBS  followed by goat anti-rabbit 1:5000 
AP-conjugated (Jackson, West Grove, PA), and detected using Immun-Star 
AP Substrate (BioRad, Hercules, CA). Cultured cardiomyocytes were fixed in 
buffered 4% formaldehyde prepared from paraformaldehyde (Sigma 
Chemical Co, St Louis, MO) for 1h, blocked with normal goat serum, stained 
with actin cytoskeleton staining with Alexa Fluor594-Phalloidin (1:400, 
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Molecular Probes, Carlsbad, CA) or immunostained with anti-NGF rabbit IgG 
(1:100, Santa Cruz Biotechnology, Santa Cruz, CA) or with anti-furin rabbit 
IgG (1:100, Santa Cruz Biotechnology, Santa Cruz, CA) and visualized using 
goat anti-rabbit IgG conjugated to cy3 (1:200, Jackson, West Grove, PA) .The 
selectivity of these antibodies has been previously confirmed, by omission 
and preabsorbtion (Hasan, et al., 2006, Wernli, et al., 2009).  
 
Sympathetic Neuronal Cultures 
To assess effects of β-AR blockade on sympathetic axon outgrowth, 
cultures were conducted on superior cervical ganglia (SCG) neurons obtained 
from Sprague-Dawley pups (postnatal day 0-2). Neurons were dissociated in 
collagenase IA (Sigma Chemical Co, St Louis, MO) followed by incubation in 
0.25% trypsin-EDTA (Sigma Chemical Co, St Louis, MO) and suspended in 
neurobasal medium (Gibco, Carlsbad, CA) with 0.5mM glutamine (Sigma 
Chemical Co, St Louis, MO), 2% B27 (Gibco, Carsbad, CA), 0.1 mg/ml 
primocin (Invivogen, San Diego, CA), FrdU and uridine (Sigma Chemical Co, 
St Louis, MO) 20μM each to reduce the number of glia and 10 ng/ml NGF 
(Alomone Labs, Jerusalem, Israel). Neurons were plated (~4x104 per well) 
onto glass coverslip (12mm diameter, Bellco glass, Vineland, NJ) preliminary 
coated with poly-D-lysine (MP Biomedicals LLC, Illkrich, France) and laminin 
(Gibco, Carsbad, CA). After adhesion of the cells, medium alone or containing 
propranolol (10-10mol/L to 10-8mol/L; Sigma Chemical Co, St Louis, MO) or 
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metoprolol (10-10mol/L to 10-6mol/L; Sigma Chemical Co, St Louis, MO) was 
added, and was changed after 24h. Other cultures were conducted in the 
presence of 10-8mol/L dobutamine (Sigma Chemical Co, St Louis, MO), with 
or without 5 μmol/L alpha-methyl-p-tyrosine (αMPT; Research Biochemicals 
International, Natick, MA).  All treatments were conducted in triplicate, and 
each experiment was repeated at least twice. 
 After 48h, cultures were fixed in buffered paraformadehyde as before 
for 1h, blocked with normal goat serum, immunostained overnight for 
peripherin (1:250, chicken IgG, Chemicon International, Billerica, MA) 
followed by a 2 h incubation in goat anti-chicken cy2 (1:200, GeneTex, San 
Antonio, TX). Six images equally distributed within each well were taken with 
a 20x objective using a Nikon Eclipse TE300 microscope. Neurite outrowth 
was calculated by superimposing a stereological grid (25μm line interval) over 
the captured image (Chakrabarty, et al., 2008), counting grid intersections 
over neurites, dividing by the total number of intersections and multiplying by 
total image area. Neurite area was then divided by the total number of somata 
in the image, and neurite outgrowth expressed as neurite area in µm2 per 
neuron. To confirm the selectivity of the staining, neurons were co-stained 
with tyrosine hydroxylase (TH, 1:300, rabbit IgG; Chemicon International, 
Billerica, MA) followed by secondary antibody goat anti-rabbit cy3 (1:200, 





RT-PCR for β1 receptor mRNA 
The presence of β1 receptors in SCG cultures was assessed by RT-PCR. 
Heart tissue and dissociated SCG cultured for 48h were homogenized in ice 
cold trizol and total RNA (1μg) was reverse transcribed using the iScript kit 
(Biorad, Hercules, CA). Amplification of cDNA was conducted using primers 
for β1 receptors (5’-CAACGGCGGGACGACCACTG -3’ sense and 5’-
ACACCTTGGACTCGGAGGAGAGC -5’ antisense). Conditions for the PCR 
were an initial heating step at 94ºC for 2min followed by 94ºC for 40 s, 59ºC 
for 30 s, and 72ºC for 1 min for 30 cycles with a final extension at 72ºC for 
5min. Five microliters of PCR product was analyzed by electrophoresis (1.5% 
agarose gel with ethidium bromide). Bands were visualized under UV 
transillumination using a Chemi Doc XRS (BioRad, Hercules, CA). 
 
Statistical Analyses 
Data were analyzed using Student T-test or one way ANOVA for 
multiple comparisons followed by a Student Newman-Keuls test (SigmaStat 
3.11, Systat Software, Inc., San Jose, CA). Data are expressed as mean ± 






























Abrupt thrombosis in a coronary artery can lead to extensive 
ventricular tissue injury (Fuster, et al., 2007). Myocyte necrosis attracts 
inflammatory cells  which secrete many factors in order to repair the ventricle 
(Frangogiannis, 2006). Nerve growth factor (NGF) is produced by several 
inflammatory cells (Zhou, et al., 2004, Hasan, et al., 2006) and we found that 
NGF from the infarcted tissue induces neuritogenesis in an explant co-culture 
system (Hasan, et al., 2006). As a result, the border region of the infarct 
becomes densely innervated with sympathetic fibers. The hyperexcitability of 
that region can lead to arrhythmias and sudden cardiac death (Vracko, et al., 
1990, Cao, et al., 2000a, Cao, et al., 2000b). Surviving individuals are at risk 
of developing congestive heart failure which is also characterized by 
sympathetic hyperexcitability (Ferrari, et al., 1998). As a result, β-blockers are 
commonly administered to reduce oxygen demand of the heart and blood 
pressure. Based on these findings, our first goal was to examine possible 
ways to downregulate sympathetic hyperinnervation following infarction by 
reducing inflammation. This may in turn restore some aspects of the electrical 
conduction in the heart. Our second goal was to study the effect of β-blockers 






Effects of anti-inflammatory drug treatments on sympathetic 
hyperinnervation 
 Dexamethasone presents advantages as a anti-inflammatory drug that 
can suppresses many inflammatory cytokines and is generally well tolerated 
(Koj, et al., 1988). Following post-infarction treatment with dexamethasone or 
saline, we first ensured that infarct size was similar between groups and the 
efficacy of the treatment was confirmed by measuring body weight. 
Dexamethasone provoked the anticipated effect by reducing body weight by 
~15% (Clark, et al., 1996, Caparroz-Assef, et al., 2007). However, we found 
that the treatment failed to reduce sympathetic innervation, suggesting that 
dexamethasone may have counteracting effects on the tropic inflammatory 
environment and on neuronal sprouting. Dexamethasone has been shown to 
increase macrophage apoptosis (Schmidt, et al., 1999), but can also increase 
macrophage colony stimulating factor, which controls macrophage growth 
and survival (Lloberas, et al., 1998). In addition, while dexamethasone 
reduces peripheral NGF (Lindholm, et al., 1994), it can also promote neuronal 
recovery (Sheehan, et al., 2006). Thus, the generalized actions of 
dexamethasone may not provide enough selectivity as a therapeutic 
treatment to reduce sympathetic hyperinnervation. 
 We previously showed that macrophages are one of the cell types 
synthesizing NGF in the infarct (Hasan, et al., 2006) and for this reason, we 
selectively targeted their depletion. Macrophages contribute to wound repair 
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by phagocytosing cellular debris (van Furth, et al., 1970, Adams, et al., 1984). 
During this process they become activated triggering the release of 
inflammatory and growth factors (Adams, et al., 1984) including NGF (Hasan, 
et al., 2006).  We administered clodronate liposomes intravenously which are 
selectively phagocytosed by macrophages and provoke their apoptosis (Van 
Rooijen, et al., 1994, van Rooijen, et al., 1996). As a result of the treatment, 
macrophages were depleted in the infarct and their reduction was associated 
with a slight decrease of myofibroblasts, suggesting that macrophages 
influence the recruitment or transdifferentiation of this cell type. T-cell 
numbers were unaffected by macrophage reduction. The depletion of 
macrophages induced a 67% reduction in mature NGF and 
immunhistochemistry analysis showed that the main inflammatory cells 
contributing to this decrease were macrophages and to a much lesser extent 
myofibroblasts.  
 Together, these results demonstrate that macrophages play a central 
role in the development of sympathetic hyperinnervation. Therefore, depleting 
macrophages could reduce arrhythmogenesis. However, macrophages are 
required for the proper healing (van Amerongen, et al., 2007) of the infarct 
and depleting this cell type may cause alternative side-effects. A possible 
method to selectively reduce their NGF production may be to target their 
activation. Phagocytosis or the presence of cytokines and chemokines are 
critical for macrophage activation (Adams, et al., 1984), which is associated 
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with upregulation of NGF production (Caroleo, et al., 2001). The use of 
macrophage gene therapy has already been the object of several studies 
(Andreesen, et al., 1990, Griffiths, et al., 2000) and it may be possible to 
introduce macrophages that produce low levels of NGF upon activation in the 
heart to reduce sympathetic hyperinnervation without impairing wound 
healing. 
 
Adrenergic receptors activation and beta-blockade 
As a result of sympathetic hyperinnervation, norepinephrine is often 
present in excessive amounts in the infarcted heart. However, besides the 
high level of innervation, sympathetic hyperactivity (Dae, et al., 1995) and 
reduced norepinephrine reuptake by the norepinephrine transporter (Li, et al., 
2004, Parrish, et al., 2008) are factors that contribute to norepinephrine 
spillover. Moreover, after infarction, axons at the base of the heart have 
elevated levels of tyrosine hydroxylase (Inoue, et al., 1988)  the rate-limiting 
enzyme in the production of norepinephrine, responsible for catalyzing the 
conversion of L-tyrosine to dihydroxyphenylalanine (DOPA), and could 
contribute to excessive norepinephrine production.  
Plasma norepinephrine levels are also elevated in congestive heart 
failure (Chidsey, et al., 1962), a frequent syndrome resulting from myocardial 
infarction. Although congestive heart failure is used as an umbrella term for 
many different complex syndromes, one common feature is the potential for 
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fluid retention and low blood pressure (Ferrari, et al., 1998). Generally 
reduced cardiac output and raised venous pressure have opposite effects on 
baroreceptor firing as an attempt to restore blood pressure, but the 
vasodilator response overwhelms the vasoconstriction response causing fluid 
rentention (Ferrari, et al., 1998). Furthermore, the presence of norepinephrine 
spillover can lead to adaptative changes in congestive heart failure by 
reducing the ratio of β1/β2 in the heart (Pritchett, et al., 2002). In addition, 
norepinephrine release is also elevated in spontaneously hypertensive rats 
(Tabei, et al., 1995, Luff, et al., 2005) and this symptom can lead to 
congestive heart failure in the absence of a previous myocardial infarction 
(Lavie, et al., 2002).   
In order to counteract some of these maladaptive changes caused by 
high norepinephrine levels, β-blockers are a frequent treatment for myocardial 
infarction, congestive heart failure and hypertension.  A number of clinical 
trials have demonstrated that β-blockers can reduce mortality and decrease 
the risk of reinfarction and adverse effects like arrhythmias and chest pain 
(Viskin, et al., 1995).  
Therefore, we studied whether adrenergic receptor activation affects 
sympathetic axonal sprouting in the heart. Although border region was 
hyperinnervated in all groups, neither the α-blocker phentolamine, nor the β-
blocker propranolol provoked any further change of innervations in that 
region. However, propranolol enhanced sympathetic innervation by nearly 
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50% in un-ischemic regions of the heart and this was also the case in 
uninjured hearts. This response was selective for β1 receptors since 
metoprolol induces the same change. On the other hand, phentolamine did 
not alter sympathetic innervation in the un-ischemic ventricular region or in 
unoperated hearts.  
During the treatments, β-blockade was confirmed by the decrease in 
heart rate with isoproterenol administration and α-blockade was demonstrated 
by the lack of pupil dilation after norepinephrine topical administration. The 
blockade of β receptors prevented the appearance of any adverse effect 
caused by sympathetic hyperinnervation. However, changes became visible 
two-days following treatment withdrawal. Propranolol-induced 
hyperinnervation increased left ventricular functions after the release of 
endogenous norepinephrine stores by tyramine compared to controls. 
Meanwhile, propranolol withdrawal lacked any effect on receptor sensitization 
since cardiac response to isoproterenol was similar to control. These results 
could explain some aspects of the dramatic findings showing that β-blocker 
discontinuation induced 24% mortality rate in patients with peripheral vascular 
disease, who are often at risk of coronary artery disease, compared to a 5% 







Because of the controversial results on sympathetic innervation 
obtained after β-blocker treatment, alternative treatments for the management 
of myocardial infarction may become increasingly used to prevent adverse 
effects. Immediately following myocardial infarction, guidelines recommend 
the administration of nitroglycerin to promote vasodilatation, morphine to 
release pain, aspirin for its anti-thrombotic effect and a β-blocker to reduce 
myocardial oxygen demand caused by hyperexcitability (Frigerio, et al., 
2005). As a continuous treatment following infarction and to treat congestive 
heart failure, it is advised to administer a diuretic, a β-blocker, an angiotensin 
II receptor blocker (ARB) or an angiotensin converting enzyme (ACE) inhibitor 
(Hunt, et al., 2005). 
ACE inhibitors downregulate the renin-angiotensin system (RAS) 
(Fauci, et al., 2008). The release of renin is induced by a decrease in renal 
blood flow and by sympathetic activation of the juxtaglomerular cells of the 
kidney. Renin cleaves angiotensinogen into angiotensin I in the plasma. 
Angiotensin I is then cleaved into angiotensin II by ACE in the pulmonary 
circulation. Angiotensin II causes primarily arteriolar vasoconstriction, which 
contributes to increasing blood pressure. After infarction and during 
congestive heart failure the RAS is upregulated, therefore ACE inhibitors are 
often administered to downregulate that system (Landmesser, et al., 2009). 
Because angiotensin II has been shown to induce neuritogenesis in PC12 
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cells and NG108-15 cells (Stroth, et al., 1998, Cote, et al., 1999, Gendron, et 
al., 2002), reducing angiotensin II via ACE inhibitor may also reduce border 
region sympathetic hyperinnervation. Therefore ACE inhibitors may not only 
attenuate maladaptive left ventricular remodeling (Landmesser, et al., 2009), 
they may also reduce hyperinnervation leading to decreased arrhythmias. 
Thus they are an important treatment, not only to reduce blood pressure but 
also to reduce cardiac sympathetic hyperactivity.  
 
Variability between β-blockers 
The main β-blockers recommended are sustained-release metoprolol 
(ie. in a matrix tablet made of hydrophilic polymers), bisprolol, which block β1 
adrenergic receptors, or carvedilol, which blocks α1, β1 and β2 adrenergic 
receptors (Hunt, 2005). Although one trial showed that carvedilol reduced 
mortality compared to metoprolol tartrate, the dose of metoprolol tartrate was 
not the conventional dose given by physicians (Hjalmarson, et al., 2000). 
Thus, carvedilol may reduce the risk of mortality due to its effects on multiple 
receptors, hence sympathetic hyperinnervation may also be reduced, but this 
needs to be further evaluated. 
 Moreover, β receptors are known to have single nucleotide  
polymorphisms (SNP) (Ahles, et al., 2009), which appear to modify drug 
efficacy. The most common SNPs are Ser49Gly located in the extracellular N 
terminus of the receptor, and Gly389Arg located in the C terminus (Tesson, et 
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al., 1999). This second variant is associated with higher adenylyl cyclase 
activity upon isoproterenol activation, consistent with its role on the C 
terminus, which conveys the response intracellularly. Due to this variability in 
genetic background and response, increasing research is being done to 
achieve individualized drug therapies.  
  
Sympathetic neuronal outgrowth and its regulation by β1 autoreceptors 
To identify the molecular mechanisms leading to β-blocker-induced 
hyperinnervation, we first determined if adrenergic-blockers mediate their 
effect by modulating cardiac NGF. We induced chemical sympathectomy with 
guanethidine (Nielsen, 1977a, Nielsen, 1977b). Although this treatment 
enhanced the production of some proNGF isoforms, total protein was 
unchanged. Moreover, adrenergic agonists did not influence NGF synthesis 
by cardiomyocytes. These results suggest that cardiac sympathetic sprouting 
induced by β-blockers is independent of target organ NGF synthesis.   
Besides NGF, other factors could modulate sympathetic innervation. In 
fact, sympathetic outgrowth is mediated by the convergence of many 
extracellular factors on receptors that trigger intracellular neurotrophic 
cascades. Besides neurotrophins, other trophic factors include adhesion 
molecules (Nagtegaal, et al., 1998), fibroblast growth factors (Delgado-
Rivera, et al., 2009) and insulin-like growth factors (Homma, et al., 2007). 
Neurotransmitters have also been identified as modulator of neuronal 
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plasticity in the central nervous system. For example, increasing doses of 
glutamate reduced axonal and dentritic outgrowth of pyramidal neurons by 
immobilizing growth cones (Mattson, et al., 1988). Likewise, dopamine 
suppressed outgrowth of neurons from the snail Helisoma (McCobb, et al., 
1988).  Serotonin had a similar effect on Helisoma neurons (Haydon, et al., 
1984). Moreover, outgrowth of serotonergic neurons from the rat raphe 
nucleus was reduced by serotonin, suggesting the regulation of outgrowth by 
an autocrine mechanism (Whitaker-Azmitia, et al., 1986).  
 Accordingly, we studied the effect of adrenergic receptor activation on 
sympathetic neuronal sprouting. We found that deactivating β adrenegic 
receptors with propranolol, metoprolol, and by decreasing norepinephrine 
content with AMPT, all induced outgrowth in a bell-shaped curve pattern. 
Moreover, maximal outgrowth by AMPT could be blocked with the selective 
β1 agonist dobutamine. These results suggest that sympathetic outgrowth is 
mediated in an autocrine fashion via β1 autoreceptors.   
 Post-ganglionic sympathetic neurons are known to express β1 
adrenoceptors (Butler, et al., 1990, Watson-Wright, et al., 1991) and we 
confirmed that sympathetic neuronal cultures express β1 receptors, however 
it is still unclear whether these receptors respond to epinephrine or to 
intraganglionic norepinephrine. Nonetheless, this suggests the presence of a 
highly complex and plastic system modulating target sympathetic innervation 
via central or peripheral feedbacks. The rapid plasticity may provide an 
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adaptive mechanism for suvival to stress. Hence high stress levels may 
reduce target organ sympathetic innervation, while low stress levels may 
increase it.  
The intracellular mechanisms leading to this neuronal plasticity remain 
unknown. However, neurotransmitter-mediated plasticity has been 
extensively studied and documented in the context of memory (Kandel, et al., 
1982). The addition of serotonin to Aplysia sensory neurons induced a 3.5-
fold increase of cAMP (Bernier, et al., 1982). Because β-receptors are 
coupled to Gs protein leading to the activation of cAMP (Lefkowitz, 2004), a 
similar reaction could result in peripheral sympathetic neurons. In 
cardiomyocytes (Wang, et al., 2004) and in Aplysia sensory neurons (Klein, et 
al., 1978), cAMP enhances the influx of Ca2+. This influx can be enhanced by 
serotonin, which decreases the probability of a specific K+ channel to open, 
which broadens the action potentials by 10 or 20 percent leading to greater 
Ca2+ influx (Klein, et al., 1980). Because a permissive range of intracellular 
Ca2+ levels appears required for maximal sprouting (Kater, et al., 1991), it is 
possible that Ca2+ mediates sympathetic neuronal outgrowth via AR, thus 
explaining the bell-shape curve effect (Fig. 1).   
Additionally, the hippocampus is one of the CNS structures with the 
highest inputs of adrenergic (norepinephrine) terminals (Schroeter, et al., 
2000), suggesting the important implication of the noradrenergic system in 
memory. In particular, the administration of β1 receptor agonist to DbH-/- mice 
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was sufficient to promote context-specific enhancement of freezing, 
suggesting that these receptors are important for memory retrieval 
(Murchison, et al., 2004).  
 Together, this suggests that an autocrine feedback similar to the one 
observed with peripheral sympathetic neurons may apply to hippocampal 
neurons of the CNS as well, hence 1) stress or hypertension which increase 
norepinephrine release may reduce neuronal plasticity and prevent the 
formation of neuronal synapses and 2) β-blockers may promote outgrowth 
followed by abnormal rewiring that could become apparent following 
withdrawal. Both could affect memory and in particular memory retrieval 
which is mediated by β1adrenegic receptor (Ouyang, et al., 2005).  
 
The future of β-blockers 
 In many cases β-blockers are required, but due to resulting 
sympathetic hyperinnervation, their use should be restricted. Starting a β-
blocker treatment should be a long term strategy and patients should be 
aware that interrupting the treatment may result in severe advese effects 
which may not outweigh their benefit. Patients unable to comply with the 
treatment regimen should also avoid taking β-blockers.  
 As it is already advised, in case patients need to withdraw from β-
blockers, the drug dosage should be reduced progressively. In addition, ACE 
inhibitors may need to be increased to counteract the effect of sympathetic 
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hyperactivity and possibly by reducing sympathetic neuronal density (Stroth, 
et al., 1998, Cote, et al., 1999, Gendron, et al., 2002). 
 Research on β receptor polymorphisms may result in increased 
selectivity of the treatment and a decrease in adverse effects. In addition, 
blocking norepinephrine release from the axons is another alternative 
treatment to reduce hyperexcitability. Because the release of norpinephrine is 
inhibited by a feedback via α2 adrenergic receptors, α2 agonists such as 
Clonidine may become increasingly administered to replace β-blockers.   
 
Conclusion 
 Collectively, these results identify macrophage NGF production as a 
central contributor to sympathetic hyperinnervation at the infarct border 
region. Therefore, macrophage NGF could be a potential therapeutic target to 
reduce post-infarction adverse effects. Secondly, our findings show that β-
blockers induce cardiac sympathetic outgrowth which results in enhanced 
ventricular neuroeffector functions. This sprouting is mediated by an autocrine 
neuronal feedback via β1 adrenergic receptors. Rapid plasticity could thus 
result as a mean for rapid physiological adaptative responses. Beta-blockers, 
which inhibit this feedback, should be administered carefully and may be 























Figure 1. Schematic showing the possible intracellular pathways leading to 
sympathetic axon outgrowth induced by norepinephrine activation of β1 
adrenoceptors. A permissive range of norepinephrine binding to β1 
adrenergic receptor may activate the Gs protein causing the activation of 
adenylate cyclase (AC) promoting the dissociation of the α subunit from the 
βγ subunits. This induces the formation of the second messenger cAMP 
followed by the activation of protein kinase A (PKA). This cascade may result 
in the release of calcium from intracellular storage and the influx of calcium 
via the L-type calcium channel. Since calcium levels are critical for growth 
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